Curriculum Vitae - Oxford Journals

A. Personal Information: 

Curriculum Vitae 

Name : Vito M. Campese, M.D. 

Professor of Medicine, Physiology and Biophysics 

Chief, Division of Nephrology 

Business Address : Los Angeles County-USC Medical Center 

2020 Zonal Avenue, IRD-806 

Los Angeles, California 90033 

Business Telephone : (323) 226-7337 

Fax Telephone : (323) 226-5390 or (323) 221-9726 

E-Mail : campese@usc.edu 

Home Address : 1510 Charlton Road 

San Marino, CA 91108-1910 

Home Phone : (626)796-9585 

Place of Birth : Bari, Italy 

Citizenship : Italian, American 

Marital Status : Married 

Spouse’s Name : Stefania 

Children : None 

B. EDUCATION: 

High School : Barletta High School, Barletta, Italy 1952 - 1957 

Liceum : Classic Liceum, Barletta, Italy 1957 - 1960 

Medical School : University of Bari, Italy 1960 - 1966 

Internship : Policlinico, Bari, Italy 1966 - 1967 

Residency : Policlinico, Bari, Italy 1967 - 1969 

Fellowship(s) : Nephrology, University of Bari, Italy 1971 - 1973 

Hypertension Service, USC Sch of Med 1974 - 1975 

Sabbatical : University of Iowa 1986 

Licensure : Italian Board of Medical Examiners 1967 

Federation Licensing Examination (FLEX) 1974 

Honors : M.D. Degree Summa Cum Laude 1966 

The Domenico Cotugno Medal and Award 1988 

In Nephrology 

The Regione Puglia Targa D'oro Award for 1991 

contribution to science 

Rotary Club Contribution to Science Award 2002 

The Mellon Award for Excellence in Mentoring 2006 

Life Achievement Award, Society Appulo- 2007 

Lucana of Nephrology 

Honorary Membership of The Italians Society 2007 

of Nephrology 

Commander of The Order of the Star of Italian 2010 

Solidarity

Curriculum Vitae Vito M. Campese, MD 

Page - 2 - 

Certification 

Certified in Nephrology, Italy 1973 

Educational Council for Foreign Medical Graduates (ECFMG) 1973 

Diplomate of the American Board of Internal Medicine 1980 

Diplomate of the American Board of Nephrology 1982 

Specialist on Hypertension 2000

C. Academic Positions: 

Department of Pharmacology, University of Bari, Italy. 1967-1972 

Assistant Professor, Institute of Nephrology, University of Bari, Italy. 1973 - 1974 

Assistant Professor, Hypertension Service, LAC-USC Medical Center, 

USC School of Medicine, Los Angeles, California. 1975 - 1977 

Assistant Professor, Division of Nephrology, LAC-USC School of 

Medicine Los Angeles, California. 1977 - 1980 

Associate Professor, Division of Nephrology, LAC-USC School of 

Medicine, Los Angeles, California. 1980 - 1985 

Professor of Medicine, Division of Nephrology, LAC-USC School of 

Medicine, Los Angeles, California. 1985-Present 

Associate Chief of the Division of Nephrology, LAC-USC School of 

Medicine, Los Angeles, California. 1987 - 1998 

Interim Chief of the Division of Nephrology, LAC-USC School of 

Medicine, Los Angeles, California. 1999 -2000 

Chief of the Division of Nephrology, LAC-USC School of Medicine, 

Los Angeles, California. 2000- Present 

Director Hypertension Center, Keck School of Medicine, USC 2003- Present 

Professor Physiology an Biophysics, Keck School of Medicine, USC 2004-Present 

Specific Teaching Responsibilities 

1967 - 1972 Teacher of Pharmacology to the Fourth Year 

Students of Medicine at the University of Bari, Italy. 

1973 - 1974 Teacher of Pharmacology to the Fellows in 

Nephrology at the University of Bari, Italy. 

1975 - 1976 Resident Supervisor on the 7th Floor Complex, Los 

Angeles County-USC Medical Center, Los Angeles, 

California. 

1976 - 1977 Physician M.D., Los Angeles County-USC Medical 

Center. 

1977 – Present Physician Specialist, Los Angeles County-USC 

Medical Center. Attending on the Renal Ward. 

Attending on Medicine 4 weeks yearly. Teacher of 

Mechanisms of Renal Disease to Year III Medical 

Students. Teacher for the Year II Renal Systems 

Course. Organizer of the Renal Pathology 

Conference. 

Military Service 

1968 - 1969 Italian Armed Service, Bari, Italy


Page - 3 - 

D. Society Memberships: 

National 

American Society of Nephrology 

The American Society of Hypertension 

Council for High Blood Pressure Research 

American Federation for Clinical Research 

American Society of Internal Medicine 

The Endocrine Society 

Western Society of Clinical Investigation 

American Physiological Society 

Western Association of Physicians 

International 

International Society of Nephrology 

International Society of Hypertension 

Field Of Interest 

Salt-Sensitivity in Hypertension. 

Hypertension Association with Renal Failure. 

Microalbuminuria in Essential Hypertension. 

Role of the Sympathetic Nervous System in Primary Hypertension 

Role of the Sympathetic Nervous System and The Kidney in Blood 

Pressure Regulation 

Autonomic Nerve Dysfuntion in Uremia. 

Orthostatic Hypotension. 

Cytokines and the neurogenic control of blood pressure.


Page - 4 - 

E. Service Record: 

Member of the Utilization Review Committee 1977 - 1979 

Member of the Advisory Council of the Kidney Foundation of 

Southern California 1977 - Present 

Member, Review Committee for Community Programs (Hypertension), 

American Heart Association of Greater Los Angeles Affiliate 1980 - 1985 

Vice-Chairman, Organizing Committee of 1st International Symposium 

on Non-Invasive Dialysis of Kidney Diseases, Vienna, Austria Sept 12-16, 1983 

Member of the Organizing Committee of the Bari Seminars of Neph- 

rology: Metabolic and Endocrine Disturbances in Renal Disease March 29-31, 1984 

Consultant on Specialized Research: Site Visit RFA - NIH -NHLBI 

- DHVD - 84-6-F at Michael Reese Hospital, Chicago, Illinois October 25, 1984 

Chairman of 25th Annual Scientific Symposium on Kidney Disease of 

The National Kidney Foundation of Southern California, Rancho Mirage September19,1985 

President of the Italian-American Society of Nephrologists 1985-89 & 1995-97 

Member of the Organizing Committee of the 2nd Bari Seminar in 

Nephrology. Acute Renal Failure: Clinical and experimental, Bari, Italy April 3 - 5, 1986 

Member of the Organizing Committee of the Verona seminars of 

Nephrology: Hypertension and Renal Disease. Verona, Italy May 1 - 3, 1986 

Chairman of the symposium. "The lipid connection in antihypertensive 

therapy." Los Angeles, California May 29, 1987 

Member of the Organizing Committee of the symposium "Advances in 

pathophysiology and management of hypertension" Bari, Italy April 10-11, 1987 

Member of the Organizing Committee of the 3rd Bari Seminars in 

Nephrology. Bari, Italy. April 20-21, 1988 

President of the 1st Review Course of Nephrology and Urology, 

Fiuggi Terme, Italy. May 9-13, 1988 

Member of the Organizing Committee of the 2nd Verona Seminar on 

Nephrology. The progressive nature of renal disease: Myths and 

Facts, Verona, Italy. Sept. 29, 1988 

NIH Study section. RFA on Hypertension and pregnancy, NIH, 

Bethesda. July 19-21, 1988 

Chairman of the Council on Hypertension of the National Kidney 

Foundation. 1988-1990 

Member of the NIH Steering Committee for an RFA on Hypertension in 

Blacks. Oct 24-25, 1989 

Consultant for Travenol on CAPD. 1985 - 1997 

Chairman of Symposium on "Recent Advance in the Management of 

Cardiovascular Renal Diseased", Los Angeles, California. Oct 27, 1990 

Member of the organizing committee of the 3rd Verona Seminar on 

Nephrology. Sept 27-29, 1990 

Chairman of the Steering Committee for an Educational Program on 

"The Kidney and Hypertension" of the National Kidney Foundation. 1990 - 1992 

Member of the Promotion Committee of the Dept. of Medicine, USC. 1989- Present 

Member of the Medical Student Research Committee. 1990 - Present 

Member of the Task Force to Develop Policy on appointment and 

promotion of voluntary faculty. 1991 

Member of the Medical Faculty Assembly. 1991 – 1994


Page - 5 - 

Service Record...Cont’d 

Member of the Joint National Committee (V) on Detection and mana- 

gement of Hypertension. 1991 

Member of the Organizing Committee of the 4th Verona Seminar on 


Member of the National High Blood Pressure Education Program 

(NHBPEP). 1991 – 1993 

Nephropathy Consensus Development Workshop. American Diabetes 

Association. San Francisco, CA. Aug 10-12, 1994 

Member of the Organizing Committee of the 5th Verona Seminar of 




Co-Chairman Symposium on Hypertension in Florence, Italy March 2, 1996 

Co-Chairman Symposium on Hypertension in Florence, Italy October 27, 1997 


Nephrology. June 26-28, 1998 

ASN Task Force on Future Research in Kidney Dis., Washington, DC. Feb. 4-5, 1999 

Co-Chairman Symposium on Hypertension in Florence, Italy April 16-17, 1999 

Member of The Program Committee of the Council on High Blood 2000 – Present 

Pressure Research, AHA . 

Member of The Professional and Public Education Committee Council 

On High Blood Pressure Research, AHA. 1999-Present 

Member of The Organizing Committee on the 8 th Verona Seminar of 

Nephology in Verona, Italy. April 6-7, 2000 

Co-Chairman Symposium on Hypertension and The Kidney in Florence, Italy Feb 24, 2001 

Chairman of Symposium “Cardio-Renal Risk and Protection in the 

Hypertensive Patient with Diabetes”. New York, N.Y. May 9-11, 2003 

Member of CME Committee of the American Society of Hypertension 2003-2006 

Member to the Clinical Science Committee of the American Society 

Of Nephrology 2003-2006 

Chairman, Symposium “Managing the diabetic with renal disease: 

Current controversies” American Society of Nephrology, San Diego, CA Nov 15, 2003 

Member of The Executive Committee of the Council on High Blood 

Pressure Research, AHA 2003 - Present 

Member of NIH Study Section “Hypertension and Microcirculation” (HM) 2003 

Member of University Committee Appointment Promotion Tenure 2005 

Chairman of University Committee Appointment Promotion Tenure 2007 

Co-Chairman “aggiornamenti in Nefrologia, 1 a edizione, Isola d’Elba 2004 




Co-Chairman “Aggiornamenti in tema di Ipertensione arteriosa, 

5 a edizione, Isola d’Elba 2008 

Chairman of Italian American Scientists and Scholars Society 2006-present 

Foundation (ISSNAF) 

Member of the NIH ad-hoc Committee for a Program Project on 2008 

Hypertension


Page - 6 - 

EDITORIAL ACTIVITY 

Assistant Editor of the American Journal of Nephrology (1980-2002). 

Editorial Board of Hypertension (1998-2003). 

Editorial Board of Journal of Hypertension (1998-2002). 

Editorial Board of American Journal Hypertension. 

Editorial Board of the Journal of Nephrology. 

Editorial Board of the Journal of the American Society of Nephrology (1992-1997). 

Editorial Guest Editor of the Symposium "The Kidney in Hypertension" published in the 

American Journal of Nephrology in 1983. 

Co-Editor with Dr. Gert Lubec of the Proceedings of the "International Symposium on 

on-Invasive Diagnosis of Kidney Diseases." 1985. 

Co-Editor with Drs A. Amerio, P. Coratelli and S.G. Massry: "Metabolic and Endocrine 

Disturbances in Renal Diseases." In Contribution to Nephrology, Vol. 49, 1985. 

Co-Editor with Drs G. Maschio, E. Valvo and L. Oldrizzi: "Hypertension and Renal Diseases." 

Contribution of Nephrology, Vol. 54, 1987. 

Co-Editor with Drs A. Amerio, P. Coratelli, S.G. Massry.: "Acute Renal Failure Clinical and 

Experimental." In: Adv. In Exp. Med. and Biol., Plenum, Vol. 212, 1987. 

Guest Editors "The Kidney and Hypertension". In Seminars in Nephr, Vol. 11, No. 5, 1991. 

Co-Editor with Drs Oldrizzi, L., Maschio, G., and Rugio, C.: “The Progressive Nature of Renal 

Disease: Myths and Facts”. Contribution to Nephrology, Vol 75, 1989. 

Co-Editor with Dr. Paolo Scarpelli of Special issue on Hyperten. J. Nephr. Vol. 11, No. 6, 1998. 

Editor of Section “Pathophysiology of Hypertension”, In Current Opinion in Nephrology and 

Hypertension Vol. 8, No. 2, 1999. 

Specialist Editors and Advisory Board “The Arab Society of Nephrology and Renal 

Transplantation”. Kidney Forum Vol. 2., No. 4, 2000. 

Editorial Board Member, Clinical Journal of the American Society of Nephrology, 2005. 

Editorial Board Member, Bentham Science Publishers Ltd., “Recent Patent Reviews on 

Cardiovascular Drug Discovery”, 2005. 

Editorial Board Member, Journal of the Cardio Metabolic Syndrome, 2005. 

Editorial Board Member, Therapeutic Advances in Cardiovascular Disease, 2008. 

Editorial Board Member, Italian Journal of Medicine, 2010. 

Associate Editor Clinical Nephrology. 

Editorial Board Member, CardioRenal Medicine, S. Kager, 2011, Jan 4 th , 2011. 

REVIEWER FOR THE FOLLOWING JOURNALS 

American Journal of Hypertension 

American Journal of Kidney Diseases 

American Journal of Medicine 

American Journal of Nephrology 

American Journal of Physiology 

Blood Purification 

Circulation 

Clinical and Experimental Hypertension 

Clinical Science 

Diabetes 


Page - 7 –

REVIEWER FOR THE FOLLOWING JOURNALS – Cont’d 

Endocrinology 

Genetica 

Geriatric Cardiovascular Medicine 

Hypertension 

International Journal of Clinical & Laboratory Research 

Journal of the American Society of Hypertension 

Journal of the American Society of Nephrology 

Journal of Cardiovascular Medicine 

Journal of Clinical Endocrinology and Metabolism 

Journal of Clinical Investigation 

Journal of Hypertension 

Journal of Human Hypertension 

REVIEWER FOR THE FOLLOWING JOURNALS…Cont’d 

Journal of Laboratory and Clinical Medicine 

Journal of Nephrology 

Kidney International 

Lancet 

Life Science 

Mayo Clinic Proceedings 

Metabolism, Clinical and Experimental 

Nephrology, Dialysis and Transplantation 

Nephron 

Neuroendocrinology 

New England Journal of Medicine 

Nutrition, Metabolism and Cardiovascular disease. 

The New England Journal of Medicine 

The Open Cardiovascular Medicine Journal 

QJM 

INVITED SPEAKER TO NATIONAL OR INTERNATIONAL MEETINGS 

Second International Symposium of Nephrology: "Secondary Forms of 

Hypertension"- Montecatini Terme, Italy, May 6-8 1980 

Lewis K. Dahl Symposium: "The Interrelation of Salt and Hypertension" 

- Brookhaven National Laboratory, Upton, Long Island, New York, May 7-8 1981 

The Tel Aviv Satellite Symposium on Acute Renal Failure - Tel Aviv, 

Israel, June 16-18 1981 

Fifth International Workshop on Phosphate and Other Minerals - New 

York, September 24-17 1981 

Advances in Nephrology - Hawaii, January 16-23 1982 

International Symposium on "Central Alpha-Adrenoceptors: Basic 

Mechanisms and Clinical Applications in Cardiovascular Disease" - 

Palm Springs, March 1982 

Thirteenth Annual Meeting, Western Dialysis and Transplant Society - 1983


Page - 8 - 

INVITED SPEAKER...Cont’d 

Las Vegas, Nevada, October 7-10 1982 

Clonidine Workshop - Schloss-Hugenpoet, Essen, Germany, Dec. 3-4. 1982 

Sixth International Workshop on Phosphate and Other Minerals - 

Verona, Italy, June 24-26 

International Symposium on Non-Invasive Diagnosis of Kidney 

Diseases - Vienna, Austria, September 12-16 1983 

International Workshop on Cardiocirculatory Function in Renal 

Diseases - Strasbourg, France, September 19-21 1983 

Annual Scientific Meeting of the National Kidney Foundation: 

Metabolic Disturbances in Uremia - Washington, D.C., December 3 1983 

Fourth Annual Midwinter Western Dialysis and Transplantation 

Society Meeting - Park City, Utah, January 20-21 1984 

The Bari Seminars in Nephrology: Metabolic and Endocrine Distur- 

bances in Renal Disease - Selva di Fasano, Italy, March 29-31 1984 

Fondazione Carlo Erba - Milano, Italy, April 6 1984 

Hypertension and the Kidney: A Labetalol Colloquium, Western 

Bonaventure Hotel, Los Angeles, CA June 11 1984 

Workshop on Calcium, Phosphate and Parathyroid Hormone in Blood 

Pressure Regulation - IXth International Congress of Nephrology, 

Los Angeles, California, June 13-19 1984 

First International Symposium on Calcium and Hypertension, Siena, 

Italy, March 15-16 1985 

Symposium on "Advances in Beta Blockade," Geneva, Switzerland, April 21 1985 

5th International Congress on Calciotropic Hormones and Calcium 

Metabolism, Venice, Italy, April 27 1985 

Annual meeting of the Mexican Society of Nephrology Mexico - City, July 10-12 1985 

Annual meeting of the Sicilian Society of Nephrology Sciacca Mare, 

Italy, September 7 - 8 1985 

2nd Bari Seminar in Nephrology. Acute Renal Failure: Clinical and 

Experimental, Bari, Italy, April 3 –5 1986 

Verona Seminars on Nephrology: Hypertension and Renal Disease, 

Verona, Italy, May 1 - 3 1986 

Clinical - Pathological Interpretation of the renal biopsy in patients with 

nephrotic syndrome. Mexico City, August 15 1986 

Fifth International Capri Conference on Uremia, Naples, Italy, September 14 - 17 1987 

First International Symposium on Hypertension, Bari, Italy, April 10-11 1987 

Ires Journees De Nephrologie De Marseille Conception, Marseille, 

France, April 26 - 29 1987 

Clonidine and centrally acting agents in the treatment of hypertension: 

Present knowledge and perspectives for the future. Florence, Italy, October 31 1987 

International conference on perspectives in molecular approaches to 

human diseases, Bari, Italy, October 26 - 31 1987 

Leading lecture at the Annual meeting of the Italian Society of 

Nephrology, Taormina, Italy , June 8 - 11 1988 

Symposium on "Calcium, The Cardiovascular System and The Kidney, 

Maui, Hawaii, April 5 - 10 1988 

1st review course of Nephrology and Urology, Fiuggi Terme, Italy, May 9 - 13 1988


Page - 9 - 


International Course of Nephrology under the auspices of the Inter- 

national Society of Nephrology. Sao Paulo, Brasil, July 20-23 1988 

2nd Verona Seminar on Nephrology: The Progressive nature of renal 

diseases: Myths and Facts. Verona, Italy. September 29, October 1 1988 

Sociedad Espanola de Nefrologia, Villanueva, Spain. October 2 - 5 1988 

20th Course on Advances in Nephrology and Dialysis: Psychological 

and physiological aspects of chronic renal failure. Milan, Italy. December 5-7 1988 

21st Course of the San Carlo Hospital on Advances in Nephrology and 

Dialysis. Milan, Italy. December 8-11 1989 

Int Congress on "Treatment and Monitoring of renal patients," Bologna, 

Italy. April 27 - 29 1989 

6th Capri Conference on Uremia. Lecture on "Sympathetic nervous 

system function in uremia". Capri, Italy September 1-4. 1989 

Meeting of the European Society of Hypertension. Milan, Italy, June. 1989 

Symposium on calcium and hypertension: Theory and clinical applica- 

tions, Phoenix, Arizona, March 22-25 1990 

Symposium on "Evolving concepts in clinical nephrology". Washington, 

D.C.. December 1 1990 

Symposium on calcium in hypertension, NARA, Japan. July 12-14. 1990 

9th Comprehensive Nephrology Review Course UCLA. August 28 1990 

3rd Verona Seminar on Nephrology - Emerging risk factors for the 

progression of renal disease. September 27-19 1990 

Symposium on: Diversity and Potential: Calcium Antagonists in the 

1990. Maui, Hawaii. Oct. 30 - November 4 1990 

Annual Meeting of the National Kidney Foundation. New Trends in the 

Pathophysiology and Management of Hypertension. Washington, 

D.C. November 30. 1990 

Symposium on: Nephrology issues in the nineties. Washington, D.C.. December 3-4 1990 

1st meeting of the Mexican Society of Hypertension. Mexico City. May 27-28. 1991 

2nd Annual Hypertension Symposium. Kalamazoo, Michigan. May 29. 1991 

Symposium "Thirty something: At the heart of it" St. Vincent Hosp. 

and Med, Ctr., Portland, Oregon. August 2. 1991 

Meeting of the Italian Society of CAPD "Cardiovascular Disease in 

CAPD". Pizzomunno, Italy. September 6-8. 1991 

Symposium on Hypertension and Coronary Disease, San Juan, 

Puerto Rico. October 20. 1991 

Symposium on cardiovascular diseases. Methodist Hospital Memphis, 

Tennessee, March 7. 1992 

Symposium on "Dietary Electrolyte intake and metabolic disturbances 

in hypertension". Paris, France. June 23-24. 1992 

4th Verona Seminar on Nephrology. Hypertension: Cause and con- 

sequence of renal damage, Verona, Italy. September 17-19. 1992 

Symposium on "Continuing Controversies in Hypertension": "Is there a 

relationship between salt-sensitivity and renal disease? NKF Annual 

Scientific Meeting, Baltimore, MD. November 13. 1993 

2nd Annual meeting of the Spanish Society of Hypertension. Madrid, 

Spain. February 10-11. 1994 

5th Verona Seminar on Nephrology. New Therapeutic Approached in 

the management of Hypertension in Patients with Renal Failure. Verona, 

Italy. September 15-17 1994


Page - 10 - 


XCV National Congress of the Italian Society of Internal Medicine. 

"Neurogenic Factors in Hypertension" Florence, Italy. October 18-21 1994 

67th Scientific Sessions, American Heart Association - Plenary Session. 

"Racial Implications in Hypertensive Disease" Dallas, Texas. November 14-17 1994 

International Congress on Hypertension in Elderly. Rome, Italy. February 2-4 1995 

International Symposium on Kidney and Hypertension Florence, Italy. March 2 1996 

11th Scientific Session Caribbean Cardiac Society, Port of Spain, Trinidad 

and Tobago, April 20th 1996 

1st Mediterranean Symposium on Cardiovascular Risk Prevention. Palermo, 

Italy May 24-25 1996 

37th Congresso Nazionale, Societa' Italiana Di Nefrologia. Cagliari, Italy 

May 29 to June 1 1996 

6th Verona Seminar on Nephrology. Ischemic Nephropathy Verona, Italy 

September 20-21 1996 

Chairman of Mini Symposium on Hypertension in Dialysis. Annual meeting 

of the ASN, New Orleans, Louisiana. November 3-6 1996 

Symposium of NHBPEP, Los Angeles, CA. March 19 1997 

37th Congresso Nazionale, Societa' Italiana Di Nefrologia. Cagliari, Italy 

May 29 to June 1 1996 

6th Verona Seminar on Nephrology. Ischemic Nephropathy Verona, Italy 

September 20-21 1996 

Chairman of Mini Symposium on Hypertension in Dialysis. Annual meeting 

of the ASN, New Orleans, Louisiana. November 3-6 1996 

Symposium of NHBPEP, Los Angeles, CA. March 19 1997 

International Symposium Kidney in Hypertension, Florence, Italy. 

October 25 1997 

Chairman, Session on Diabetic Nephrology, ASN, San Antonio, Texas. 

November 4 1997 

Hypertension and Progression of Renal Disease, University of Bari, 

Bari, Italy. November 27 1997 

Black Health Care Coalition Symposium. Kansas City, Missouri. 

November 20 1997 

University of Davis, Sacramento, CA. January 13 1998 

2nd Mediterranean Symposium on Cardiovascular Risk Prevention. 

Palermo, Italy. May 28-30 1998 

Symposium on Hypertension, Warsaw, Poland. June 3 1998 

7th Verona Seminar on Nephrology, Verona, Italy. June 26-27 1998 

Symposium on prevention of complications in dialysis patients. Capri 

Italy. September 4-5 1998 

Symposium on Lipids and Renal Disease, Osaka, Japan. October 8-10 1998 

Clinical Nephrology Symposia “Treatment of Hypertension: Newer 

Approaches”, American Society of Nephrology, Philadelphia, PA. 

October 25-28 1998 

Chairman Session on Pathogenesis and Consequences of Hypertension, 

American Society of Nephrology, Philadelphia, PA. October 25-28 1998 

2nd International Symposium on The Kidney In Hypertension, Florence, Italy. 

April 17, 1999 1999 

The Predialysis Management of Hypertension. Symposium on Managing 

Hypertension: A Challenge to The Nephrologist in The 21th Century. ASN, 

Miami, Florida. November 3-8 1999


Page - 11 - 

VISITING PROFESSORSHIPS 

ASH-Laragh Conference on “Hypertension and The New Biology of Obesity 

January 13-15 2000 

8 th Verona Seminar of Nephrology Progression of Renal Disease in the 3 rd 

Millennium in Verona, Italy, April 6-7. 2000 

Hypertension and The Kidney in The 3 rd Millennium, “Prevention and Treatment 

Of Hypertension in Renal Disease”, in Taormina, Italy, April 8. 

Management of Hypertension with a focus on the African American Family”. 

Long Beach, California. April 27-30 2000 

Postgraduate Education Courses: Pharmacologic Management of Hypertension: 

Role of the Sympathetic Nervous System, in Toranto, Canada, Oct. 11. 2000 

Update in the Treatment of Hypertension in Dearborn, MI. Nov. 18. 2000 

Kidney and Hypertension: “Vasopeptidases inhibitors: molecular basis and 

Clinical applications”, in Florence, Italy, Feb. 24. 2001 

Spanish Society of Hyertension: Salt Sensitivity and Hypertension in Malaga, 

Spain, March 10-13. 2001 

The 4 th Annual Seminar for People with Diabetes and Their Family in 

Los Angeles, CA., June 9. 2001 

The 9 th Verona Seminar on Nephrology. “COX-2 inhibitors and renal disease” 

Verona, Italy, April 5 th 2002 

7 th SNS Working Group Meeting, Genova, Italy “Kidney, SNS, and 

hypertension”. Genova (Italy) September 7 th 2002 

Latino Heath Care Conference: “Hypertension: Implications for Aggressive 

Therapy, Latino Population at Risk”, in Los Angeles, CA, Oct. 26-27. 2002 

35 th Annual Meeting, American Society of Nephrology, Philadelphia, PA. 

November 1-3. 2002 

Annual Meeting of the Japanese Society of Hypertension, Japan, Oct 11-13 2002 

“The kidney and the neurogenic control of blood pressure. 

Annual Meeting of the American Society of Nephrology: “The kidney and the 

Neurogenic control of blood pressure” October 30 th , Philadelphia 2002 

University of Rome 

Hypertension in Chronic Renal Failure, January 28, 2003 2003 

Annual Meeting of Pri-Med Society Long Beach, CA 

The challenge of controlling BP in high risk patients, April 5 th 2003 

CAFP’s 55 th Annual Scientific Assembly, Los Angeles 

New trends in the Management of Hypertension, April 12 th 2003 

Annual Meeting of the Experimental Biology Society, San Diego 

“The Kidney and the Neurogenic Control of BP” April 13 th 2003 

“Statins and Kidney Disease, ANMCO 2004”, Florence, Italy, May 23 rd 2004 

International Symposium “Lipid Abnormalities In Chronic Kidney Disease” 

October 10-11, Bologna, Italy. 2003 

Round-Table Discussion “Sympathetic Nervous System and the Kidney” 

36 t Annual Meeting of the American Society of Nephrology. San Diego, CA 2003 

International Symposium “Lipid Abnormalities In Chronic Kidney Disease” 

October 10-11, Bologna, Italy. 2003 

Round-Table Discussion “Sympathetic Nervous System and the Kidney” 

36 t Annual Meeting of the American Society of Nephrology. San Diego, CA 2003 

Division of Nephrology, University of Utah, March 29-31. 1983 

Div. of Cardiology, University of Turin, Italy, June 17. 1983 

Department of Internal Medicine, University of Palermo, Italy, June 28 1983 

Division of Cardiology, University of Rome, Policlinico, Rome, June 29. 1983


Page - 12 - 

VISITING PROFESSORSHIPS…Cont’d 

Department of Medicine, University of Brussels, Erasme Hospital, 

Bruxelles, Belgium, July 7. 1983 

Division of Nephrology, Centre Hospitalier De Luxembourg, 

Luxembourg, July 8. 1983 

Division of Nephrology, Veterans Administration, University of New 

Mexico School of Medicine, Albuquerque, New Mexico, March 22. 1984 

Department of Medicine, Clinica Medica I, University of Bari, Italy, March 28. 1984 

Division of Nephrology and Dialysis, Ospedale Niguarda Ca' Granda, 

Milan, Italy, April 6. 1984 

Division of Nephrology, Baylor College of Medicine Houston, Texas. October 22-23. 1985 

Nassau Medical Center, New York, December. 1987 

Dept. of Med., Univ. of Toledo, Toledo, OH. September 8-9. 1987 

Division of Nephrology, University of West-Virginia, Morgantown, 

West Virgina, September 22-24. 1987 

VA Hospital, Washington, D.C., June 6. 1988 

Division of Nephrology, University of Chieti, Chieti, Italy, April 26 – 27. 1989 

UCLA Nephrology Training Programs. March 28-30. 1990 

University of Adana, Turkey. October 10-13. 1990 

University of Alabama, Birmingham, Alabama. May 14-15. 1991 

University of Kentucky, Lexington, Kentucky. November 13. 1991 

University of Louisville. Louisville, Kentucky. November 19. 1991 

University of Louisiana, Shreveport, Louisiana. May 12. 1992 

University of Louisiana, Shreveport, Louisiana, April 4-5 1994 

University of Louisiana, Shreveport, Louisiana, March 6-7 1995 

University of Virginia, Richmond, Virginia, March 19 1996 

University of Alabama, Birmingham, Alabama. September 2 1997 

University of Naples, Italy. October 20-21 1997 

Cleveland Clinic, Cleveland, Ohio. April 24 1998 

University of Palermo, Italy, June 22-25 1998 

University of Modena, Italy, April 6-8 1999 

University of Kansas, Dept. of Physiology, November 4 2002 

University of Portland, Division of Nephrology, January 9-10 2003 

University of Washington, Division of Nephrology, January 25-27 2006 

University of Florida, Gainsville, FL March 1-2 2007


Page - 13 - 

Articles Published 

1. CAMPESE, V.M.: Azione della morfina e della stricnina sul riflesso da stiramento 

dell'intestino Ileo di cavia. Arch Sci Biol 51: 283-287, 1967. 

2. CAMPESE, V.M., G. Siro-Brigiani, E. Antoncecchi: Sul potenziamento da cocaina di 

sostanze ad attivita' tono-stimolante. Accad Pugl Sci 25: 443-451, 1967. 

3. SIRO-BRIGIANI, G., V.M. Campese, E. Antoncecchi: I Beta-recettori e L'Interferenza 

della cocaina con le catecolamine. Accad Pugl Sci 25: 453-451, 1967. 

4. CALO, V., V.M. Campese, D. Mitolo-Chieppa: Relazione fra struttura ed effetto 

farmacologico di derivati piridinici. Accad Pugl Sci 26: 989-995, 1968. 

5. PADOLECCHIA, N., S. Maggi, G. Maiorano, V. Fasano, V.M. Campese: Proposition 

d'une modification au test de Jirgl pour une meilleure differenciation des icteres. Arch 

Franc Malad App Dig (Paris) 57: 437-446, 1968. 

6. CAMPESE, V.M., D. Mitolo-Chieppa: Indagine sul meccanismo vasorilassante della 

nicotina condotta attraverso una analisi dei gruppi funzionali della sostanza. Boll Soc 

Ital Biol Sper 44: 2212-2214, 1968. 

7. MITOLO-CHIEPPA, D., V.M. Campese: Importanza del tono miogeno per evidenziare i 

B-recettori su preparati arteriosi Isolati. Boll Soc Ital Biol Sper 44: 1542-1566, 1969. 

8. PESE, V.M., G. Siro-Brigiani: Polenziamento da cocaina di sostanze ad attivita 

no-stimolante su arterie isolate. Boll Soc Ital Biol Sper 45: 1564-1566, 1969. 

9. CAMPESE, V.M., G. Siro-Brigiani: Interferenza della cocaina con l'attivita'tono 

stimolante di alcuni farmaci su arterie isolate. Accad Pugl Sci 27: 117-121, 1969. 

10. SIRO-BRIGIANI, G., V.M. Campese, E. Antoncecchi: Azione coleretica di alcuni 

diuretici nel ratto. Accad Pugl Sci 28: 120-123, 1970. 

11. SIRO-BRIGIANI, G., V.M. Campese, E. Antoncecchi: Azione coleretica del 

furosemide e della teofillina nel ratto. Boll Soc Ital Biol Sper 46: 607-609, 1970. 

12. SIRO-BRIGIANI, G., V.M. Campese, M. Rubino: Sul meccanismo dell'effetto contratturante 

del DMPP sull'esofago paracardiale acalasico. Accad Pugl Sci 28: 1-10, 1970. 

13. MITOLO-CHIEPPA, D., V.M. Campese: Effetti della bradichinina su nodo di Ranvier di 

fibre nervose isolate di rana. Boll Soc Ital Sper 47: 631-633, 1971. 

14. SIRO-BRIGIANI, G., V.M. Campese, M. Rubino: Studio sui recettori adrenergici del 

terzo inferiore dell'esofago e del cardias umano. Boll Soc Ital Biol Sper 47: 20-21, 1971.


Page - 14 - 

15. CAMPESE, V.M., G. Siro-Brigiani: Azione coleretica dell'acido etacrinico nel ratto. Boll 

Soc Ital Biol Sper 47: 22-24, 1971. 

16. SIRO-BRIGIANI, G., V.M. Campese, M. Rubino: Azione farmacologica del DMPP sul 

cardias umano. Boll Soc Ital Biol Sper 47: 24-26, 1971. 

17. CAMPESE, V.M., D. Mitolo-Chieppa, V. Calo: Relazione fra struttura e proprieta' 

miorilassante dei derivati piridinici. Boll Soc Ital Biol Sper 48: 717-720, 1972. 

18. CAMPESE, V.M., V. Cuomo, R. Russo, A. Marino: Effetti di un nuovo 

benzodiazepinico (bromazepam) sull'intestino isolato di cavia. Boll Soc Ital Biol Sper 

48: 807-809, 1972. 

19. CAMPESE, V.M., D. Mitolo-Chieppa: The effects of bradykinin on single Ranvier node 

of nerve fibres in the frog. In: Vasopeptides: Chemistry, Pharmacology and 

Pathophysiology. Edited by N. Beck and F. Sicuteri, Adv Exp Med Biol 21: 477-482, 

1972. 

20. AMERIO, A., P. Coratelli, V.M. Campese: The use of anticoagulants and 

dipyridamole in malignant hypertension and glomerulonephritis. In: Platelet 

Aggregation, Ediz. Boehringer, Milan, p. 115-121, 1972. 

21. CAMPESE, V.M., F. Marzullo, F.P. Schena, P. Coratelli: Acute renal failure during 

intermittent rifampicin therapy. Nephron 10: 256-261, 1973. 

22. CAMPESE, V.M.: Effetti del dipiridamolo sull'intestino isolato di cavia. Boll Soc 

Ital Biol Sper 48: 809-811, 1973. 

23. CORATELLI, P., M. Rovito, V.M. Campese: L'angiocolite ittero-uremigena. Minerva 

Nephrol 19: 341-350, 1973. 

24. MARINO, A, VM Campese: Farmaci antiipertensivi. Clin Ter 66:465-494, 1973. 

25. CAMPESE, V.M., A. Marino: Fisio-farmacologia delle insufficienze coronariche. 

Clin Ter I: 69: 299-326, 1974. 

26. CAMPESE, V. M., A. Marino: Fisio-farmacologia delle insufficienze coronariche. 

Clin Ter II: 69: 399-429, 1974. 

27. CAMPESE, V.M., G. Managanella: Nefrotossicita' degli antibiotici. Clin Ter 71: 

469-489, 1974. 

28. MARINO, A., V.M. Campese, V. Cuomo, P. Calabrese: Infuenza del bromazepam e 

del diazepam sulla tossicita' acuta e sulle alterazioni ecgrafiche da nicotina nella cavia. 

Boll Soc Ital Biol Sper 50: 769-774, 1974.


Page - 15 - 

29. MARINO, A., V.M. Campese, E. Cuomo, P. Calabrese: Influenza del bromazepam sulla 

tossicita' subacuta e sulle alterazioni ecgrafiche da nicotina nella cavia. Boll Soc Ital 

Biol Sper 50: 775-779, 1974. 

30. CORATELLI, P., V.M. Campese, A. Amerio: Terapia medica della ipertensione 

maligna. Minerva Nephrol 21: 323-333, 1974. 

31. AMERIO, A., P. Coratelli, V.M. Campese, F. D'Agostino, G. Pastore, M. Rovito: 

L'insufficienza renale acuta post-abortum. Minerva Nephrol 21: 95-103, 1974. 

32. PASTORE, G., V.M. Campese, F. Dagostino, et al: L'insufficienza renale nel 

colera asiatico. Minerva Nephrol 22: 272-280, 1975. 

33. CAMPESE, V.M.: Effetti del dipiridamolo sull'utero isolato di ratto. Boll Soc Ital Biol 

Sper 50: 1322-1325, 1975. 

34. AMERIO, A., P. Pastore, V.M. Campese, et al: Complicanze Renali nel colera 

asiatico. Ann Sclavo 17: 419-434, 1975. 

35. DeQUATTRO, V., V.M. Campese, Y. Miura, D. Meijer: Biochemical markers of 

sympathetic nerve activity and renin in primary hypertension. In: Pathophysiology and 

Management of Arterial Hypertension. Edited by G. Berglund, L. Hansson and L. 

Werko. Molndal, Sweden: A Lindgren & Soner AB, 1975, p. 23-31. 

36. DeQUATTRO, V., Y. Miura, V.M. Campese, S. Brunjes: Catecholamines biosynthesis in 

man: Effects of hypertension and reserpine. In: Recent advances in Hypertension, Vol. 

Edited by P. Milliez and M. Safar. Paris, France: Laboratories Boehringer 

Ingelheim, 1975, p. 13-26. 

37. DeQUATTRO, V., V.M. Campese, A. Lurvey, et al: Low response of serum dopamine 

B-hydroxylase to stimuli in primary hypertension. Biochem Med 15: 1-9, 1976, USA. 

38. DeQUATTRO, V., V.M. Campese, Y. Miura, N. Esler: Sympathotonia in primary 

hypertension and in a caricature resembling dysautonomia. Clin Sci Mol Med 51: 

435s-438s, 1976, London, U.K.. 

39. DeQUATTRO, V., V.M. Campese, Y. Miura, D. Meijer: Increased plasma 

catecholamines in "high" renin hypertension. Am J Cardiol 38: 801-804, 1976, USA. 

40. MIURA, Y., V.M. Campese, V. DeQuattro, D. Meijer: Plasma catecholamines via an 

improved fluorimetric assay: comparison with an enzymatic method. J Lab Clin Med 

89:421 - 427, 1977, USA. 

41. DeQUATTRO, V., B. H. Barbour, V. M. Campese, E. J. Finck, L. Miano, M. Esler: 

Sympathetic nerve hyperactivity in "high" renin hypertension. Effects of saralasin 

infusion. Mayo Clin Proc 52: 369 - 373, 1977, USA.


Page - 16 - 

42. DeQUATTRO, V., V.M. Campese, M.J. Antonaccio: Hypertension: Etiology 

pathophysiology and control. In: Introduction to Cardiovascular Pharmacology, Ed. M. 

J. Antonaccio, New York, Raven Press, 1977, pp. 185 - 268. 

43. DeQUATTRO, V., V.M. Campese, M. Esler: Primary hypertension: How hemodynamic 

and renin states relate to sympathetic nerve tone. Cardiovasc Med 3: 267 - 277, 1978, 

USA. 

44. EIDE, I., V.M. Campese, D. Stein, K. Eide, V. DeQuattro: Clinical assessment of 

sympathetic tone: Orthostatic blood pressure responses in borderline primary 

hypertension. Clin Exp Hypertension 1: 51 - 65, 1978, USA. 

45. KEUSCH, G. W., P. Weidmann, V.M. Campese, D.B.N. Lee, A.T. Upham, S.G. 

Massry: Minoxidil therapy in refractory hypertension. Analysis of 155 patients. Nephron 

21: 1 - 15, 1978, Switzerland. 

46. DeQUATTRO, V., V.M. Campese, M. Esler: El Sistema nervioso simpatico y la renina 

en la hipertension primaria. Tribuna Medica 39: 27-31, 1978. (Madrid, Spain). 

47. ROMOFF, M.S., G. Keusch, V.M. Campese, M.S. Wang, R.M. Friedler, P. Weidmann, 

S.G. Massry: Effect of sodium intake on plasma catecholamines in normal subjects. 

J Clin Endocrinol Metab 48: 26-31, 1978. (USA). 

48. DeQUATTRO, V., M.R. Meyers, V.M. Campese: Anatomy and biochemistry of the 

sympathetic nervous system. In: Metabolic Basis of Endocrinology, Ed. L. DeGroot, 

Grune & Stratton, New York, USA, 1979 pp. 1241 - 1260. 

49. DeQUATTRO, V., V. M. Campese: Functional components of the sympathetic nervous 

system: Regulation of organ system, Ed. L. DeGroot, Grune & Stratton, New York, 

USA, 1979, pp. 1261 - 1278. 

50. DeQUATTRO, V., V.M. Campese: Pheochromocytoma: Diagnosis and therapy. In: 

Metab Basis of Endocrinol, Ed. L. DeGroot, Grune & Stratton, NY, 1979, pp. 1279 - 

1288, USA. 

51. CAMPESE, V.M., V. DeQuattro: Orthostatic hypotension: Causes and therapy. In: 

Metabolic Basis of Endocrinology, Ed. L. DeGroot, Grune & Stratton, New York, USA, 

1979, pp. 1289 - 1295. 

52. DeQUATTRO, V., I. Eide, R. Koloch, L. Miano, V. Campese, J. Van der Meulen: 

Peripheral and central markers of neurogenic tone in primary hypertension. In: 

"Perspectives in Neurology and Medicine." Henri Schmitt, et al, Eds., New York, John 

Wiley and Sons, and Paris, Flammanson, 1979, pp. 311-317. (USA). 

53. MASSRY, S.G., D.A. Golstein, W.R. Procci, O.A. Kletzky, V.M. Campese, M.S. Romoff, 

J. Dixon: Impotence in uremia. Is it an organic or psychologic disorder? 

Controversies in Nephrology, Ed. G.E. Schreiner. January 18-19, 1979 pp. 150-162, 

USA.


Page - 17 - 

54. CAMPESE, V.M., D. Stein, V. DeQuattro: Treatment of severe hypertension with 

minoxidil: Advantages and limitaions. J Clin Pharmacol 19: 231-241, 1979. (USA). 

55. CAMPESE, V.M., M.R. Myers, V. DeQuattro: Neurogenic factors in low renin essential 

hypertension. Am J Med 69: 83-91, 1980, USA. 

56. CAMPESE, V.M., M. Romoff, V. DeQuattro, S.G. Massry: Relationship between 

plasma catecholamines, plasma renin activity, aldosterone, and arterial pressure 

during postural stress in normal subjects. J Lab Clin Med 96; 927-933, 1980. (USA). 

57. CAMPESE, V.M., M. Romoff, N. Telfer, P. Weidmann, S.G. Massry: Role of 

sympathetic nerve inhibition and body sodium-volume state in the antihypertensive 

action of clonidine in essential hypertension. Kidney Internat 18: 351-357, 1980. 

New York, USA. 

58. AMERIO, A., V.M. Campese, P. Coratelli, F. Dagostino, M. Micelli, G. Passavanti, 

F. Petrarulo: Prognosis in Acute Renal Failure Accompanied by Jaundice. Nephron 27: 

152-154, 1981. (Switzerland). 

59. CAMPESE, V.M., M.S. Romoff, D. Levitan, K. Lane, S.G. Massry: Mechanisms of autonomic 

nervous system dysfunction in uremia. Kid. Internat 20:246-253, 1981, N.Y., 

USA. 

60. CAMPESE, V.M.: Minoxidil: A review of its pharmacological properties and therapeutic 

use. Drugs 22: 257-278, 1981. (Australia). 

61. CAMPESE, V.M., M. Romoff, N. Telfer, Y. Saglikes, S. Massry: Mechanisms of 

antihypertensive activity of clonidine in essential hypertension. In: Secondary Forms 

of Hypertension. Ed. M.D. Blaufox and C. Bianchi. Grune & Stratton, USA, 1981, pp. 

29-31. 

62. CAMPESE, V.M.: Salt and neurogenic variables in essential hypertension. In: Salt and 

hypertension. Ed. J. Iwai, Igaku-Shoin, New York (USA), pp. 259-274, 1982. 

63. MASSRY, S.G., V.M. Campese: Functional abnormalities of the autonomic nervous 

system uremic and dialysis patients. In: Prevention of Kidney Disease and Long-term 

survival, Ed. M.M. Avram, Pleanum Med Book Company, (USA); 117-130, 1982. 

64. CAMPESE, V.M.: Natrium- und volumenbilanz bei hypertonikern unter clonidin. 

Clonidin-Workshop, Essen, Germany 3/4 December, 1982. 

65. CAMPESE, V.M., M.S. Romoff, D. Levitan, Y. Saglikes, R. Friedler, S.G. Massry: Abnormal 

relationship between sodium intake and sympathetic nervous system activity in 

salt-sensitive patients with essential hypertension. Kidney Internat 21: 371-378, 

1982.


Page - 18 – 

66. CAMPESE, V.M., W.R. Procci, D. Levitan, M.S. Romoff, D.A. Goldstein, S.G. Massry: 

Autonomic nervous system dysfunction and impotence in uremia. Am J Nephrol 2: 

140-143, 1982, Basel, Switzerland. 

67. LEVITAN, D., S.G. Massry, M.S. Romoff, V.M. Campese: Autonomic nervous system 

dysfunction in patients with acute renal failure. Am J Nephrol 2:213-220, 1982. Basel, 

Switzerland. 

68. CAMPESE, VM, D Levitan, MS Romoff, Y Saglikes, I Sajo, SG Massry: Effect of sympa 

thetic nerve inhibition on the state of sodium-volume balance in hypertensive pa-tients 

with normal or impaired renal function. Clin Sci 63:301s-303s, 1982, London, U.K.. 

69. CAMPESE, V.M., Massry, S.G.: Effect of acute and chronic treatment with clonidine. 

Chest 83 (Suppl) pp. 380s-383s, 1983. 

70. CAMPESE, V.M.: Sympatho-adrenal system and the kidney in hypertension. Am J 

Nephrol 3: 128-138, 1983. Basel, Switzerland. 

71. CAMPESE, V.M.: Sodium and volume balance in hypertensive subjects taking 

clonidine. In: Central blood pressure regulation. Dr. D. Steinkopff Verlag, 89-99, 1983, 

Germany. 

72. MASSRY, S.G., V.M. Campese: Autonomic nervous system dysfunction. In: Textbook 

of Nephrology, Eds. S.G. Massry and R.J. Glassock, Williams and Wilkins Publisher, 

Baltimore, Maryland, USA, 1983, pp 7.19-7.21. 

73. CAMPESE, V.M., A.C. Novello, Y. Saglikes: Diagnostic value of plasma and urinary 

catecholamines in nephrology. In: Non-invasive diagnosis of kidney disease, Eds. G. 

Lubec, John Libbey & Co., Ltd., London, U.K., 1983. 

74. CAMPESE, V.M., J. Sowers, M. Golub, M. Conolly: Hypertension. In: Current 

Nephrology, Ed. H.C. Gonick, John Wiley & Sons, N Y, USA, Vol. 7:267-298, 1984. 

75 CAMPESE, V.M.: Hypertension in CRF, in dialysis, and in renal transplant recipients. 

In: Current Therapy in Nephrology and Hypertension 1984-1985, Ed. R.J. Glassock, 

B.C. Decker Inc., Philadelphia, USA, 1984, pp. 353-363. 

76. LEVITAN, D., S.G. Massry, M. Romoff, V.M. Campese: Plasma catecholamines and 

autonomic nervous system function in patients with early renal insufficiency and 

hypertension: Effect of clonidine. Nephron 36:24-29, 1984, Basel, Switzerland. 

77. ELKAYAM, U., L. Weber, V.M. Campese, S. G. Massry, and S. H. Rahimtoola: Renal 

hemodynamic effects of vasodilation with nifedipine and hydralazine in patients with 

heart failure. J Am College Cardiol 4: 1261-1267, 1984, USA. 

78. BREAM, R., V.M. Campese, S.G. Massry, S.H. Rahimtoola, P.A.N. Chandraratna: 

Subdiaphragmatic fluid mimicking loculated pericardial effusion on the echocardiogram. 

Am J Cardiol 54: 1388-1389, 1984, USA.


Page - 19 - 

79. CAMPESE, V.M., Y. Saglikes, K. Iseki, S.G. Massry: The relationship between body 

phosphate and blood pressure. In: Phosphate and Mineral Metabolism. Plenum 

Publish. Co., New York, USA, Adv. Expl. Med. Biol. 178: 271-274, 1984. 

80. CAMPESE, V.M., R.E. Easterling, F. Finkelstein, M. Mattern, D.A. Ogden, R.W. Steiner, 

D.G. Oreopoulos: Renal osteodystrophy and the status of aluminum and other trace 

metals in CAPD Patients: A panel review. Peritoneal Dialysis Bulletin 4: 129-136, 

1984, Toronto, Canada. 

81. CAMPESE, V.M.: Discussion pp. 262-265, in Feinstein, E.I., Hypertension in renal 

transplant recipients. Am J Nephrol 4: 262-271, 1984, Basel, Switzerland. 

82. CAMPESE, V.M., K. Iseki and S.G. Massry: Plasma catecholamines and vascular 

reactivity in uremic and dialysis patients. Contr Nephrol 41: 90-98, 1984, Basel, 

Switzerland. 

83. McCarron, D.A., Lau, K., Niser, R.L., Resnick, L., Campese, V.M., Mann, J., Bushinsky, 

D.: Calcium, phosphate, and Parathyroid Hormone in Blood Pressure Regulation. Proc. 

IX Cong. Nephrol. Ed Robinson, R.R. Springer-Verlag, New York, USA, pp 1141-1147, 

1984. 

84. CAMPESE, V.M.: Diagnosis of autonomic nerve dysfunction in uremia. In: Advances in 

non-invasive nephrology, Eds. G. Lubec and V.M. Campese, John Libbey & Co., Ltd. 

1985 pp. 85-93, London, U.K.. 

85. CAMPESE, V.M., K. Iseki and S.G. Massry: Calcium, phosphate and parathyroid 

hormone in arterial pressure regulation in the rat. In: Proc. 5th Intl. Congr. on 

Calciotropic Hormones and Calcium Metabolism (ed., M. Cecchettin), Excerpta Medica, 

Amsterdam, The Netherlands, pp 81-88, 1985. 

86. COLLINS, J., S.G. Massry, V.M. Campese: Parathyroid hormone and the altered 

vascular response to norepinephrine in uremia. Am J Nephrol 5: 110-113, 1985, 

Basel, Switzerland. 

87. SAGLIKES, Y., S.G. Massry, K. Iseki, N. Brautbar, R. Barndt, L.L. Brunton, I.L.D. 

Buxton, N. Vlachakis, V.M. Campese: Effect of phosphate depletion on blood pressure 

and vascular reactivity to norepinephrine and angiotensin II in rat. Am J Physiol 248: 

F93-F99, 1985, USA. 

88. SAGLIKES, Y., S.G. Massry, K. Iseki, J.L. Nadler, V.M. Campese: Effect of PTH on 

blood pressure and response to vasoconstrictor agonists. Am J Physiol 248: 

F674-F681, 1985, USA. 

89. ISEKI, K., S.G. Massry, V.M. Campese: Evidence for a role of PTH in the reduced 

pressor response to norepinephrine in chronic renal failure. Kidney Int. 28: 11-15, 1985, 

Basel, Switerland.


Page - 20 – 

90. CAMPESE, V.M., E.I. Feinstein, V. Gura, J.W. Mason, S.G. Massry: -Pharmacokinetics 

of atenolol in patients treated with chronic hemodialysis or peritoneal dialysis. J Clin 

Pharmacol 25: 393-395, 1985. 

91. CAMPESE, V.M., Massry, S.G.: Plasma Catecholamines and Vascular Reactivity in 

Acute and Chronic Renal Failure. In: Metabolic and Endocrine Disturbances in Renal 

Disease. Ed. Amerio A., Coratelli, P., Campese, V.M., Massry, S.G., Contributions to 

Neprhology. Karger, Basel, Switzerland, 1985, pp 128-133. 

92. CAMPESE, V.M.: Adrenergic nervous system in hypertension. In: Metabolic and 

Endocrine Disturbances in Renal Disease. Ed: Amerio A., Coratelli, P., Campese, V.M., 

Massry, S.G.: Contribution to Nephrology 49:145-155, 1985. 

93. NADLER, J.L., McKay, M., Campese, V.M., Horton, R.: Prostacyclin modulates the 

vascular actions of calcium in man. Adv Prost Throm Leukotrine Res 15: 441-443, 

1985, USA. 

94. CAMPESE, V.M., and Massry, S.G.: Autonomic nervous system dysfunction in uremia. 

Clin. Update Nephrol.1: No. 21:1-11, 1985, USA. 

95. El-BELBESSI, S., N. Brautbar, K. Anderson, V.M. Campese and S.G. Massry: Effect of 

CRF on heart: Role of secondary hyperparathyroidism. Amer. J. Nephrol. 6: 369-375, 

1986. 

96. CAMPESE, V.M.: Management of hypertension in chronic dialysis patients. In: Dialysis 

Therapy. Ed Nissenson, A.R., Fine, R.N., Hanley & Belfus, Inc., Philadelphia (USA) 

1986, pp. 182 - 186. 

97. NADLER, J.L., Mc Kay, M., Campese, V.M., Vrbanac, J., Horton, R.: Evidence that 

prostacyclin modulates the vascular actions of calcium in man. J Clin Invest 

77:1278-1284, 1986, USA. 

98. ISEKI, K., S.G. Massry and V.M. Campese: Effects of hypercalcemia and PTH on 

blood pressure in normal and renal failure rats. Am J Physiol 250: F924-F929, 1986. 

99. MASSRY, S.G., Iseki, K., Campese, V.M.: Serum Calcium, parathyroid hormone and 

blood pressure. Amer. J. Nephrol. 6: S19 - S28, 1986, Basel, Switzerland. 

100. LEMPERT, K.D., Kolb, J. A., Swartz, R.D., Campese, V.M., et al: A multi center trial to 

evaluate the use of the CAPD "O" set. Trans Am Soc Artif Intern Organs 32: 557-559, 

1986 (USA). 

101. SOLIMAN, M., Massry, S.G., Campese, V.M.: Renal hemodynamics and 

pharmacokinetics of bevantolol in patients with impaired renal function. Amer J Cardiol 

58: 21E-24E, 1986, (USA). 

102. CAMPESE, V.M.: Calcium, Parathyroid Hormone, and sympathoadrenal system. Am J 

Nephrol 61 (Supp II): 29 - 32, 1986, Basel, Switzerland.


Page - 21 - 

103. CAMPESE, V.M.: Management of essential hypertesnion. Whom, When and How to 

treat. Contr Nephrol 54: 38 - 53, 1987, Basel, Switzerland. 

104. KULICK, D.L., McIntosh, N., Campese, V.M., Hsueh, W., Rahimtoola, S. H., Massry, 

S.G., Elkayam, U.: Central and renal hemodynamic effects and hormonal responses to 

diltiazem in severe congestive heart failure. Am J Cardiol 59: 1138 - 1143, 1987, USA. 

105. BHASKARAN, D., Massry, S.G., Campese, V.M.: Effects of hypophosphatemia on brain 

catecholamines content in the rat. Mineral Electrol Metab. 13: 469 - 472, 1987, Basel, 

Switzerland. 

106. CAMPESE, V.M., Iseki, K.: Contrast-Induced Acute Renal Failure. Plenum Press, New 

York, USA. Adv. Exp. Med. Biol. 212: 135-144, 1987. 

107. CAMPESE, V.M., Hsueh, W.: Recent advances in the role of the renal nervous system 

and renin in hypertension. In: Contemporary Nephrology Vol. 4, Eds: Klahr, S., Massry, 

S.G., Plenum Med, New York, USA,1987, 283 - 322. 

108. CAMPESE, V.M.: Hypertension in CRF. Pathogenesis and management. Mediguide 

Nephrol 2: 1-4, 1987, USA. 

109. CAMPESE, V.M., Individualized care in essential hypertension. In: Current therapy in 

nephrology and hypertension. Ed. Glassock, R.J., B.C. Decker, Inc., Philadelphia, USA, 

1987, pp. 287 - 291. 

110. CAMPESE, V.M., Cardiovascular instability during hemodialysis. Kidney Int 33 (Suppl 

24): S186 - S190, 1988, New York, USA. 

111. CAMPESE, V.M.: Orthostatic hypotension: Idiopathic and Uremic. Kidney International 

34: S152-S155, 1988, New York, USA. 

112. FADDA, G., Massry, S.G., El-Refai, M., Campese, V.M.: Alpha1 adrenergic receptors in 

mesenteric arteries of rats with chronic renal failure. Kidney International 34: 463-466, 

1988, New York, USA. 

113. CAMPESE, V.M.: Effects of calcium antagonists on deranged modulation of the renal 

function curve in salt-sensitive patients with essential hypertension. Am J Cardiol 62: 

85G-91G, 1988. 

114. CAMPESE, V.M.: Effect of antihypertensive agents of renal function and on 

sodium-volume status. Adv Exp Med Biol 252: 331-346, 1988. 

115. CAMPESE, V.M., Liu, C.I.: Sexual dysfunctions in uremia: Endocrine and neurologic 

abnormalities. Att Nefrol Dial, Eds G. D'Amico, C. Bazzi, G. Colasanti, Wichting Ed 

Milano, 1988, pp 3-11. 

116. DeQUATTRO, V., Myers, M., Campese, V.M.: Anatomy and biochemistry of the 

symapthetic nervous system. In: Endocrinology, 2nd edition, Ed. L.J. DeGroot, 

Saunders, Co., Philadelphia, USA, 1989, pp 1717-1737.


Page - 22 - 

117. CAMPESE, V.M., DeQuattro, V.: Functional components of the sympathetic nervous 

system. In: Endocrinology, 2nd Edition, Ed. L.J. DeGroot, Saunders Co., Philadelphia, 

USA, 1989, pp 1736-1756. 

118. CAMPESE, V.M., DeQuattro, V.: Orthostatic hypotension: causes and therapy. In: 

Endocrinology, 2nd edition, Ed. L.J. DeGroot, Saunders Co. Philadelphia, USA, 

1989, pp 1757-1766. 

119. DeQUATTRO, V., Myers, M., Campese, V.M.: Pheochromocytoma: Diagnosis and 

therapy. In: Endocrinology, 2nd Edition, Ed. L.J. DeGroot, Saunders Co., Philadelphia, 

USA, 1989, pp 1780-1797. 

120. CAMPESE, V.M.: Calcium, parathyroid hormone, and blood pressure. Am J Hypert 2: 

34S-44S, 1989. 

121. CAMPESE, V.M.: Metabolism of catecholamines in uraemia. In Molecular Aspects of 

Human Disease, Eds J. Gorrod, O. Albano, S. Papa, Ellis Horwood Ltd. Pb, pp 

185-191, 1989. 

122. CAMPESE, V.M., Massry, S.G.: Autonomic nervous system. In Textbook of 

Nephrology, Eds, Massry, S.G. and Glassock, R.J. Williams & Wilkins, 162-1165, 1989. 

123. SMOGORZEWSKI, M., Campese, V.M., Massry, S.G.: Abnormal norepinephrine uptake 

and release in brain synaptosomes in CRF. Kidney Int 36: 458-465, 1989. 

124. CAMPESE, V.M.: Sodium, calcium and neurogenic factors in the pathogenesis of 

essential hypertension. In Contemporary Nephrology, Vol. 5, Eds S. Klahr and S.G. 

Massry, Plenum Publs., 1989, 189-215. 

125. CAMPESE, V.M.: Sodium and calcium metabolism in the pathophysiology of essential 

hypertension (Editorial). Nefrologia 9: 347-352, 1989. 

126. CAMPESE, V.M.: Hipertension en la insuficiencia renal cronica y en receptores de 

transplante. In: Insuficiencia renal cronica, Eds Llach and Valderrabano, Ediciones 

Norma, 1990. pp 159-178. 

127. CAMPESE, V.M.: Minoxidil. In cardiovascular drug therapy. Ed. Messerli, F.H., W.B. 

Saunders Co. 1990, pp. 849-860. 

128. CAMPESE, V.M.: Autonomic nervous system dysfunction in uremia. Nephrol. Dial. 

Transplant 1990 (Suppl. I): 98-101. 

129. CAMPESE, V.M.: Hypertension in the salt-sensitive patient. Prod. by Medicine 

International, New York, 1990. 

130. CAMPESE, V.M.: The role of renal nerves in hypertension. In: Issues in Nephroscience, 

Eds. G. D'Amico and G. Colasanti, Wichtig Editore Milano, 1991, pp. 54-60.


Page - 23 - 

131. BIANCHI, S., Bigazzi, R., Baldari, G., and Campese, V.M.: Microalbuminuria in patients 

with essential hypertension. Effects of an angiotensin converting enzyme inhibitor and 

of a calcium channel blocker. Am. J. Hypertension 1991; 4: 291-296. 

132. GADALLAH, M, Massry, SG, Bigazzi, R, Horst, RL, Eggena, P and VM Campese: 

Intestinal absorption of calcium and calcium metabolism in patients with essential 

hypertension and normal renal function. Am J Hypertension 4:404-409, 1991. 

133. CAMPESE, V.M., Bigazzi, R.: The role of hypertension in the progression of renal 

disease. Am. J. Kidney Disease 1991, 5 (Suppl 1): 43-47. 

134. BIANCHI, S., Bigazzi, R., Baldari, G., Campese, V.M.: Long-Term effects of enalapril 

and nicardipine on urinary albumin excretion in patients with chronic renal insufficiency. 

Am. J. Nephrol. 1991, 11: 131-137. 

135. CAMPESE, V.M., Karubian, F.: Salt-sensitivity in Hypertension: Implications for the 

kidney. JASN 1991; 2(Suppl.):S53-S61. 

136. CAMPESE, V.M., Parise, M., Karubian, F., Bigazzi, R.: Abnormal renal hemodynamics 

in black salt-sensitive patients with hypertension. Hypertension 1991; 18:805-812. 

137. CAMPESE, V.M., Bigazzi, R.: Hypertension in chronic renal failure, dialysis, and 

transplantation. In: Current Therapy in Nephrology and Hypertension, Ed. Glassock, 

B.C. Decker Pb., 1991; 391-405. 

138. CAMPESE, V.M., Karubian, F.: Renal consequence of salt and hypertenstion. Sem. 

Nephrol. 1991; 11: 549-560. 

139. CAMPESE, V.M., Karubian, F., Bigazzi, R.: Cardiovascular risk factors in patients on 

CAPD. In "Dialisi peritoneale. Vl Convegno Nazionale di Dialisi Peritoneale. 

Foggia-Vieste 6-8, Sept., 1991, pp 81-105. 

140. CHERVU, I., Koss, M., Campese, V.M.: Bilateral Renal cortical necrosis in two patients 

with Neisseria meningitidis sepsis. Am. J. Nephrol. 1991, 11:411-415. 

141. BUCHANAN, T.A., Sipos, G.F., Madrilejo, N., Liu, C., Campese, V.M.: Hypertension 

without peripheral insulin resistance in spontaneously hypertensive rats. Am. J. Physiol. 

1992, 262:E14-E19. 

142. BIGAZZI, R., Bianchi, S., Campese, V.M.: Lung diseases in the uremic patient. Quad 

Pat. 1992; 1:69-80. 

143. BUCHANAN, T.A., Joun, J.H., Campese, V.M., Sipos, G.F.: Enhanced glucose 

tolerance in spontaneously hypertensive rats. Diabetes, 1992; 41: 872-878.


Page - 24 - 

144. ALEXIEWICZ, J.M., Gaciong, Z., Parise, M., Karubian, F., Massry, S.G., and Campese, 

V.M.: Effect of dietary sodium intake on intracellular calcium in lymphocytes of 

salt-sensitive hypertensive patients. Am. J. Hypertens. 1992; 5:536-541. 

145. LIU, C.L., Bigazzi, R., Ballard, J., and Campese, V.M.: Effect of hypercalcemia on renal 

sympathetic nervous system activity. Am. J. Nephrol. 1992; 12:86-93. 

146. BIGAZZI, R., Bianchi, S., Campese, V.M., and Baldari, G.: Prevalence of 

microalbuminuria in a large population of patients with mild to moderate essential 

hypertension. Nephron 1992; 61:94-97. 

147. CHERVU, I., Karubian, F., Campese, V.M.: The role of endothelial factors, cyclosporine, 

and erythropoietin in hypertension in chronic renal failure. Current Opinion in 

Cardiology 1992; 7:776-781. 

148. BIANCHI, S., Bigazzi, R., Baldari, G., Campese, V.M.: Microalbuminuria in patients with 

essential hypertension: Effects of several antihypertensive drugs. Am. J. Med. 1992; 

93:525-528. 

149. GADALLAH, M.F., Bashir, A., Karubian, F., Campese, V.M.: Pregnancy in Patients on 

Chronic Ambulatory Peritoneal Dialysis. American Journal of Kidney Diseases 

4:407-410, 1992. 

150. KARUBIAN, F.J., Chervu, I., Campese, V.M.: Hypertension in chronic dialysis patients. 

In dialysis therapy, Ed. A.R. Nissenson and R.N. Fine. Hanley & Belfus, Inc. 

Philadelphia, 1992. pp 243-252. 

151. BIGAZZI, R., Bianchi, S., Baldari, D., Scherri, G., Baldari, G., Campese, V.M.: 

Long-term effects of a converting enzyme inhibitor and a calcium channel blocker on 

urinary albumin excretion in patients with essential hypertension. Am. J. Hypertension 

1992; 6:108-113. 

152. GADALLAH, M.F., El-Shahawy, M.A., Campese, V.M.: Unilateral breast enlargement 

secondary to hemodialysis arteriovenous fistula and subclavian vein occlusion. 

Nephron 1993; 63:351-353. 

153. CAMPESE, V.M., Karubian, F., Chervu, I., Parise, M., Sarkies, N., Bigazzi, R.: Pressor 

reactivity to norepinephrine and angiotensin in salt-sensitive hypertensive patients. 

Hypertension 1993; 21:301-307. 

154. CAMPESE, V.M., Karubian, F., Bigazzi, R.: Hemodynamic alterations and urinary 

albumin excretion in patients with essential hypertension. Am. J. Kidney Dis. 21 (Suppl. 

2): 15-21, 1993. 

155. CAMPESE, V.M.: The kidney and hypertension. In: Cardiovascular risk factors. 1993; 

9-11.


Page - 25 - 

156. CAMPESE, V.M.: Renal Parenchymal Disease Pathophysiology. In Hypertension 

Primer. Eds. Izzo JI, Black Hr. From the Council on High Blood Pressure Research, Am. 

Heart Assoc. 1993, pp 101-103. 

157. CAMPESE, V.M.: The Fifth Report of the Joint National Committee of Detection, 

Evaluation and Treatment of high blood pressure (JNC V). Arch Int Med 1993; 153: 

154-183. 

158. BIGAZZI, R., Bianchi, S., Baldari, D., Sgherri, G., Baldari, G., Campese, V.M.: 

Microalbuminuria in salt-sensitive patients - A marker for renal and cardiovascular risk 

factors. Hypertension 1994; 23:195-199. 

159. BIANCHI, S., Bigazzi, R., Baldari, G., Sgherri, G., Campese, V.M.: Diurnal variations of 

blood pressure and microalbuminuria in essential hypertension. Am. J. Hypertension 

1994; 7:23-29. 

160. GARBER, A.J., Campese, V.M., Franz, M.J., et al: Consensus development 

conference on the diagnosis and management of nephropathy in patients with diabetes 

mellitus. Diabetes Care 1994, 17:1357-1361. 

161. CAMPESE, V.M., Chervu, I.: Hypertension in dialysis subjects: In Principles and 

Practice of Dialysis. W.L. Henrich Ed., Williams & Wilkins Publisher, Baltimore, 1994, 

148-169. 

162. CAMPESE, V.M.: Salt-Sensitivity in hypertension. Renal and cardiovascular 

implications. Hypertension 1994; 23:531-550. 

163. EL-SHAHAWY, M.A., GADALLAH, M.F., CAMPESE, V.M.: Tuberculosis of the Spine 

(Pott's Disease) in patients with End-Stage Renal Disease. Am. J. Nephrol. 1994; 

14:55-59. 

164. BIGAZZI, R., Kogosov, E., Campese, V.M.: Altered norepinephrine turnover in the 

brown fat of rats with chronic renal failure. JASN 1994; 4:1896-1900. 

165. BIGAZZI, R., Kogosov, E., Campese, V.M.: Altered norepinephrine turnover in the brain 

of rats with chronic renal failure. JASN 1994; 4:1901-1907. 

166. BIANCHI, S., Bigazzi, R., Valtriani, C., Chiapponi, I., Sgherri, G., Baldari, G., Natali, 

A., Ferranini, E., Campese, V.M.: Elevated serum insulin in patients with essential 

hypertension and microalbuminuria. Hypertension 1994; 23: 681-687. 

167. LIOU, H.H., Chiang, S.S., Wu, S.C., Huang, T.P., Campese, V.M., Smogorzewski, M., 

Yang, W.C.: Hypokalemic effects of intravenous infusion or nebulization of salbutamol in 

patients with chronic renal failure: Comparative study. Am. J. Kidney Dis. 1994; 

23:266-271.


Page - 26 - 

168. CAMPESE, V.M.: Pathophysiology of essential hypertension. In: Testbook of 

Nephrology, Eds. Massry, S.G. and R.J. Glassock, Williams and Wilkins Pbs., 

Baltimore, MD, U.S.A. 1994, pp 1169-1185. 

169. CAMPESE, V.M.: Clinical aspects and management of essential hypertension. In: 

Testbook of Nephrology, Eds. Massry, S.G. and R.J. Glassock, Williams and Wilkins 

Pbs., Baltimore, MD, U.S.A. 1994, pp 1186-1217. 

170. CAMPESE, V.M. and Massry, S.G.: Autonomic nervous system in uremia. In: Testbook 

of Nephrology, Eds. Massry, S.G. and R.J. Glassock, Williams and Wilkins Pbs., 

Baltimore, MD, U.S.A. 1994, pp 1334-1338. 

171. CAMPESE, V.M.: Neurogenic factors in hypertension: Therapeutic Implications. Ann. 

Ital. Med. Int. 1994; 9(Suppl.): 39s-43s. 

172. CAMPESE, V.M.: Is Hypertension in Chronic Renal Failure Neurogenic in Nature? 

Editorial Comments. Nephrol. Dial. Transplant. 1994; 9:741-742. 

173. LIOU, H.H., HUANG, T.P., CAMPESE, V.M.: Effect of long-term therapy with captopril 

on proteinuria and renal function in patients with non-insulin-dependent diabetes and 

with non-diabetic renal diseases. Nephron 1995; 69:41-48. 

174. CAMPESE, V.M., KOGOSOV, E.: Renal afferent denervation prevents hypertension in 

rats with chronic renal failure. Hypertension 1995; 25 [Part 2]:878-882. 

175. CAMPESE, V.M., KOGOSOV, E., KOSS, M.: Renal afferent denervation prevents the 

progression of renal disease in the renal ablation model of chronic renal failure in the 

rat. Am. J. Kidney Dis. 1995; 26:861-895. 

176. BIGAZZI, R., BIANCHI, S., NENCI, R., BALDARI, D., AND V.M. CAMPESE: Increased 

thickness of the carotid artery in patients with essential hypertension and 

microalbuminuria. J. Human Hypertension 1995; 9:827-833. 

177. EL-SHAHAWY, M., MESA, C., KOSS, M., CAMPESE, V.M.: Clinical pathology 

conference: A 19 year-old female with fever, acroparesthesia, and progressive 

deterioration of renal function. Am. J. Nephrol. 1996; 16:417-424. 

178. BIGAZZI, R., BIANCHI, S., BALDARI, G., CAMPESE, V.M.: Clustering of cardiovascular 

risk factors in salt-sensitive patients with essential hypertension: Role of insulin. Am. J. 

Hypertension 1996; 9:24-32. 

179. CAMPESE, V.M.: The Kidney in The Hypertensive Black. Ethnicity and Health 1996; 

2:145-151. 

180. GADALLAH, M.F., EL-SHAHAWY, M.A., CAMPESE, V.M., TODD, J.R., KING, J.W.: 

Disparate prognosis of thrombotic microangiopathy in HIV - infected patients with and 

without AIDS. Am. J. Nephrol. 1996; 16:446-450.


Page - 27 - 

181. CAMPESE, V.M., BIANCHI, S.: Is deterioration of renal function in essential 

hypertension predictable? Contrib. Nephrol. 1996; 119:83-90. 

182. CAMPESE, V.M., TAWADROUS, M., BIGAZZI, R., BIANCHI, S., MANN, A.S., OPARIL, 

S., RAIJ, L.: Salt intake and plasma atrial natriuretic peptide and nitric oxide in 

hypertension. Hypertension 1996; 28:335-340. 

183. CAMPESE, V.M.: Management of the hypertensive dialysis patient treated with epoetin 

alfa. In Issue and Outcomes in Anemia, Ed. N.W. Levin, Pb ML Mecom, 1996. 

184. CAMPESE, V.M.: Neurogenic factors in hypertensive patients with chronic renal failure 

and on dialysis. Sem. Dialysis 1996; 9:390-391. 

185. CAMPESE, V.M., BIANCHI, S.: Nutritional Factors in Hypertension. In: Nutritional 

Management of Renal Disease. Eds. Joel D. Kopple and Shaul G. Massry. Williams & 

Wilkins, pp 77-95, 1996. 

186. CAMPESE, V.M.: Why is salt sensitive hypertension so common in blacks? Hypothesis. 

Nephrol. Dial. Transplant 12:399-403, 1996. 

187. YE, S., OZGUR, B., CAMPESE, V.M.: Renal afferent impulses, the posterior 

hypothalamus, and hypertension in rats with chronic renal failure. Kidney Int. 1997; 

51:722-727. 

188. YE, S., NOSRATI, AND V.M. CAMPESE: Nitric Oxide (NO) Modulates the Neurogenic 

Control of Blood Pressure in Rats with Chronic Renal Failure (CRF). J. Clin. Invest. 

1997; 99(3): 540-548. 

189. TOTO, RD, KIRK, KA, CORESH, J, JONES, C, APPEL, L, WRIGHT, J, CAMPESE, VM, 

OLUTADE, B, AGODOA, L. The AASK Pilot Study Investigators. Evaluation of Serum 

Cretinine of Estimating Glomerular Filtration Rate in African Americans with 

Hypertensive Nephrosclerosis: Results from the African-American Study of Kidney 

Disease and Hypertension (AASK) Pilot Study. J. Am. Soc. Nephrol. 1997; 8:279-287. 

190. CAMPESE, V.M.: Neurogenic factors and hypertension in chronic renal failure. J. 

Nephrol. 1997; 10:184-187. 

191. BIANCHI, S., BIGAZZI, R., CAMPESE, V.M.: Microalbuminuria in essential hypertension. 

J. Nephrol. 1997; 10:216-219. 

192. CAMPESE, V.M., BIANCHI, S., BIGAZZI, R.: Hypertension, Hyperlipidemia and 

Microalbuminuria. In: Lipids and the kidney. Keane, W.F. Horl, W.H., and Kasiske, B.L. 

eds. Contrib. Nephrol. 1997; 120:11-21 

193. CAMPESE, V.M., AMAR, M., ANJALI, C., MEDHAT, T., AND A. WURGAFT: Effect of Larginine 

on systemic and renal haemodynamics in salt-sensitive patients with essential 

hypertension. J. Human Hypertension 11:527-532, 1997.


Page - 28 - 

194. CAMPESE, VM, BIANCHI, S: Hypertension in end-stage renal disease and after renal 

transplantation. Ed. F. Llach and F. Valderrabano, Edisones Norma, Madrid, 1997, pp 

205-230. 

195. BIANCHI, S., BIGAZZI, R., NENCI, R., CAMPESE, V.M.: Hyperinsulinemia, circadian 

variation of blood pressure and end organ damage in hypertension. J. Nephrol. 1997; 

10:325-333. 

196. BIANCHI, S., BIGAZZI, R., CAMPESE, V.M.: Altered circadian blood pressure profere 

and renal damage. Blood Pressure monitoring 1997; 2:339-345. 

197. CAMPESE, VM, ARORA, A: Hypertension in Dialysis Patients. In Principles and 

Practice of Dialysis. W.L. Henrich Ed., Williams & Wilkins Publisher, Baltimore 1998; 

209-234. 

198. BIGAZZI, R., BIANCHI, S., BALDARI, D., CAMPESE, V.M.: Microalbuminuria predicts 

cardiovascular events and renal insufficiency in patients with essential hypertension. J. 

Hypertension 16:1325-1333, 1998. 

199. YE, S., GAMBURD, M., MOZAYENI, P., KOSS, M., CAMPESE, V.M.: A limited renal 

injury may cause a permanent form of neurogenic hypertension. Am. J. Hypertension 

1998; 11:723-728. 

200. CAMPESE, V.M.: Renal parenchymal hypertension. In: Hypertension Primer. Eds. 

IZZO, JL, Black HR, 1998. 

201. BIANCHI, S., BIGAZZI, R., CAMPESE, V.M.: Microalbuminuria in patients with essential 

hypertension as compared to diabetes. In Mogensen CE: The Kidney and Hypertension 

in diabetes mellitus, 4th Edition, Kluwer Academic Pub., Boston, 1998. 

202. CAMPESE, V.M., WURGAFT, A., SAFA, M., BIANCHI, S.: Dietary salt intake, blood 

pressure and the kidney in hypertensive patients with non-insulin dependent diabetes 

mellitus. J. Nephrol. 1998; 11:289-295. 

203. BIANCHI, S., BIGAZZI, R., CAMPESE, V.M.: Microalbuminuria in patients with essential 

hypertension, cardiovascular and renal implications. In The Kidney and Hypertension in 

Diabetes Mellitus (4th Ed.) C.E. Mogensen; Kluwer Academic Publishers, 1998, 569- 

584. 

204. CAMPESE, V.M.: The kidney and the neurogenic control of blood pressure in renal 

disease. Current Opinion Nephrology and Hypertension 1999; 8:213-216. 

205. CAMPESE, V.M. AND NOSRATI, S.: Secondary Hypertension. Clinical Cornerstone 

1999, 2:27-35. 

206. BIANCHI S., BIGAZZI, R., AND CAMPESE, V.M.: Microalbuminuria in essential 

hypertension: Significance, pathophysiology, and therapeutic implications. Am. J. 

Kidney Dis. 1999, 34:973-995.


Page - 29 – 

207. CAMPESE, VM, WIDERHORN, ALM: Natriuretic Peptide. In Hypertension, Eds. Oparil 

S, Weber M, Saunders WB Co. 1999, pp 165-176. 

208. CAMPESE, V.M.: Salt-sensitive hypertension: Renal and cardiovascular implications. 

Nutr. Metab. Cardiovasc. Dis. 1999; 9:143-156. 

209. CAMPESE, V.M. AND MOZAYENI, P.: Hypertension Secondary to Parenchymal Renal 

Diseases. Clinical Nephrology Dialysis and Transplantation, ed. Malluche, 1999; 1-12. 

210. CAMPESE, VM, BIANCHI, S, BIGAZZI, R: Association between hyperlipidemia and 

microalbuminuria in essential hypertension. Kidney Int. 56:(Suppl. 71)S10-S13, 1999. 

211. CAMPESE, V.M., BIANCHI, S. AND BIGAZZI, R.: Is microalbuminuria a predictor of 

cardiovascular and renal disease in patients with essential hypertension? Current 

Opinion in Nephr. 2000; 9:143-147. 

212. CAMPESE, V.M.: Neurogenic factors and hypertension in renal disease. Kidney Int. 

57:(Suppl. 75)S2-S6, 2000. 

213. CAMPESE, V.M., YE, S-H, TRUONG, R.H., GAMBURD, M.: Losartan reduces 

sympathetic nerve outflow from the brain of rats with chronic renal failure. JRAAS 2000, 

1(2): 202-208. 

214. CAMPESE, V.M., BIGAZZI, R., AND BIANCHI, S.: Microalbuminuria in essential 

hypertension. Significance for the cardiovascular and renal systems. The Kidney and 

Hypertension In Diabetes Melliuts. 2000 by Kluwer Academic publishers, Fifth Edition, 

Edited by Carl Erik Mogensen. 

215. YE, S., MOZAYENI P, GAMBURD M, ZHONG, H., AND CAMPESE VM: Interleukin-1b 

and the neurogenic control of blood pressure in rats with chronic renal failure. Am. J. 

Physiol. Heart Circ Physiol 279(6): H2786-H2796, 2000. 

216. CAMPESE, V.M.: The kidney and the neurogenic control of blood pressure in renal 

disease. J. Nephrol 12:221-224, 2000. 

217. CAMPESE, V.M.: Pathophysiology of Essential Hypertension. In: Textbook of 

Nephrology, 4 th Edition, Eds. Massry, S.G. and R.J. Glassock, Williams and Wilkins 

Pbs., Baltimore, MD, U.S.A. 2001, pp 1121-1135. 

218. CAMPESE, V.M., TANASESCU, A. AND MASSRY, S.G.: Autonomic Nervous System. 

In: Textbook of Nephrology, 4 th Edition, Eds. Massry, S.G. and R.J. Glassock, Williams 

and Wilkins Pbs., Baltimore, MD, U.S.A. 2001, pp 1287-1291. 

219. CAMPESE, V.M., LASSETER, K.C., FERRARIO, C.M., SMITH, W.B., RUDDY, M.C., 

GRIM, C.E., SMITH, R.D., VARGAS, R., HABASHY, M.F., VESTERQVIST, O., 

DELANEY, C.L., AND LIAO, W-C.: Omapatrilat Versus Lisinopril Efficacy and 

Neurohormonal Profile in Salt-Sensitive Hypertension Patients. Hypertension 2001; 

38:1342-1348.


Page - 30 – 

220. MAILLOUX, L.U., FIELDS, S. AND CAMPESE, V.M.: Cardiovascular Disease 

Hypertension in Chronic Dialysis Patients. In: Dialysis Therapy (3 rd Edition, Nissenson, 

A.R. and Fine, R.N. [Editors]). Hanley & Belfus, Inc., Philadelphia, PA, U.S.A. 2002, pp 

341-352 (Section 21). 

221. CAMPESE, V.M., YE, S-H. AND ZHONG, H.: Downregulation of Neuronal Nitric Oxide 

Synthase and Interleukin-1ß Mediates Angiotensin II-Dependent Stimulation of 

Sympathetic Nerve Activity. Hypertension 2002; 39 [2 Part 2]: 519-524. 

222. CAMPESE, V.M., KROL E: Neurogenic factors in renal hypertension. Current 

Hypertension Reports. 4(3):256-60, 2002. 

223. Ye S, Zhong H, Duong VN, Campese VM: Losartan reduces central and peripheral 

sympathetic nerve activity in a rat model of neurogenic hypertension. Hypertension. 

39(6):1101-6, 2002. 

224. Ye S, Zhong H, Yanamadala V, and Campese VM: Renal Injury Caused by Intrarenal 

Injection of Phenol Increases Afferent and Efferent Renal Sympathetic Nerve Activity. 

AJH 15(8):717-724, 2002. 

225. Ferrario, C.M., Smith, R.D., Brosnihan, B., Chappell, M.C., Campese, V.M., Vesterqvist, 

O., Liao, W-C., Ruddy, M.C., Clarence, E.G.: Effect of Omapatrilat on the Renin- 

Angiotensin System in Salt-Sensitive Hypertension. AJH 15(6): 557-564, 2002. 

226. Campese, V.M., Mozayeni, P., Ye, S-H., Gumbard, M.: High salt intake inhibits nitric 

oxide synthase expression and aggravates hypertension in rats with chronic renal 

failure. J. Nephrol. 15(4): 407-413, 2002. 

227. Campese, V.M. and Krol, E.: Salt Sensitivity and Microalbuminuria: Implications for 

Pathogenesis and Management. In: Calcium Antagonists in Clinical Medicine. 3 rd 

Edition, Murray Epstein, M.D., FACP Hanley & Belfus, Inc., Philadelphia, Pennsylvania, 

pp681-700, 2002. 

228. Campese, V.M., Krol, E.: Neurogenic factors in renal hypertension. Curr Hypertens Rep 

2002;4(3):256-260. 

229. YANG, LE., LEONG, P.K., YE, S., CAMPESE, V.M., McDONOUGH, A.A.: Responses 

of proximal tubule sodium transporters to acute injury-induced hypertension. Am J. 

Physiol Renal Physiol 2003; 284(2): :F313-F322. 

230. YANG, LE., LEONG, P.K., Perianayagam, A., Campese, V.M., McDONOUGH, A.A.: 

Chronic renal injury-induced hypertension alters renal NHE3 distribution and 

abundance. 2003; 284 (5): F1056-F1065. 

231. CAMPESE, V.M. Pathophysiology of renal parenchymal hypertension. Hypertension 

Primer (3 rd Ediiton; Izzo, JL, Black HT [Editors]). Lippincott William & Wilkins, 

Philadelphia, PA, pp. 141-143, 2003.


Page - 31 – 

232. Bianchi, S., Bigazzi, R., Caiazza, A., and Campese, V.M.: A Controlled, Prospectivie 

Study of the Effects of Atorvastatin on Proteinuria and Progression of Kidney Disease. 

Am. J. Kidney Dis. 41(3): 565-570, 2003. 

233. Bianchi, S., Bigazzi, R., Amoroso, A., and Campese, V.M.: Silent ischemia is more 

prevalent among hypertensive patients with microalbuminuria and salt sensitivity. 

Journal of Human Hypertension 17: 13-20, 2003. 

234. CAMPESE, V.M., Rezvani F: Aldosterone blockade for the treatment of hypertension. 

In: Univ. Reports on Recent Advances in Aldosterone Blockade: The Emerging 

Treatment for Cardiorenal Diseases (Parmley [Editor]). Associates in Medical 

Marketing Company, Inc., Newtown, PA, pp. 1-12, 2003. 

235. CAMPESE, V.M.: A new model of neurogenic hypertension caused by renal injury: 

pathophysiology and therapeutic implications. Clin. Exp. Nephrol. 7(3):167-171, 2003. 

236. Epstein, M. and Campese, V.M.: Evolving role of calcium antagonists in the 

management of hypertension. In: Medical Clinics of North America, (Frohlich, E.D., 

[Editor]) W.B. Saunders, Philadelphia, PA, 88(1): 149-165, 2004. 

237. CAMPESE, V.M., Bigazzi, R., and Bianchi, S.: Microalbuminuria In Essential 

Hypertension: Cardiovascular And Renal Implications. In: The Kidney and 

Hypertension in Diabetes Mellitus (6 th Edition, Mogensen [Editor], Chapter 41). Taylor & 

Francis, London, UK, pp.785-800, 2004. 

238. Davidson, M.B., Bazargan, M., Bakris, G., Harmel, A.P., Campese, V.M. and Basta, E.: 

ImmunoDip: an Improved Screening Method for Microalbuminuria. Am J Nephrol 24(3): 

284-848, 2004. 

239. Campese, VM, Ye, S-H, Zhong, H, Yanamadala, V, Ye Zhong, and Chiu, J: Reactive 

oxygen species stimulate central and peripheral sympathetic nervous system activity. 

Am J Physiol Heart Circ Physiol 287(2):H695-H703, 2004. 

240. CAMPESE, VM, TANASESCU, A.: Hypertension in Dialysis Patients. In: Principle and 

Practice of Dialysis (3 rd Edition, Henrich, WL [Editor]), Lippincott Williams & Wilkins, 

Philadelphia, PA. (Chapter 16, Part II), pp. 227-256, 2004. 

241. NADIM, MK, DUA, R, AND CAMPESE, VM: Antihypertensive Drugs and the Kidney. 

Current Cardiology Reports 6(6): 403-408, 2004. 

242. CAMPESE, VM, NADIM, MK: Natriuretic Peptides. In: Hypertension, Companion to 

Brenner & Rector’s The Kidney (2 nd Edition; Oparil, S. and Weber, M.). Elsevier 

Saunders, Philadelphia, PA., Chapter 18, pp. 169-192, 2005. 

243. CAMPESE, VM, Nadim, MK, and Epstein, M: Are 3-Hydroxy-3-Methylglutaryl-CoA 

Reductase Inhibitors Renoprotective? J. Am. Soc. Nephrol. 16 Suppl.(1): S11-S17, 

2005. 

244. CAMPESE, VM: Clinical Practice Guidelines for Cardiovascular Disease in Dialysis 

Patients. Am. J. Kidney Dis. (Work Group), Vol. 45, No. 4, Suppl. 3, S1-S153, 2005.


Page - 32 - 

245. Bianchi, S, Bigazzi, R and CAMPESE, VM: Antagonists of Aldosterone and Proteinuria 

in Patients With CKD: An Uncontrolled Pilot Study. Am J Kidney Dis 46(1):45-51, 2005. 

246. Epstein, M. and CAMPESE, V.M.: Pleiotropic effects of 3-hydroxy-3-methylglutaryl 

coenzyme a reductase inhibitors on renal function. Am J Kidney Dis. 2005; 45(1):2-14. 

247. CAMPESE, V.M., Ye, S-H, Zhong, H.: Oxidative Stress Mediates Angiotensin II- 

Dependent Stimulation of Sympathetic Nerve Activity. Hypertension 46(3):533-539, 

2005. 

248. CAMPESE, V.M., Hadaya, B., and Chiu, J.: HMG-CoA Reductase Inhibitors and the 

Kidney. Curr. Hyperten. Rep. 2005; 7(5):337-342. 

249. Sica, D.A., Thomas, D.G., Black, H.R. and Campese, V.M.: ACE Inhibitors: Over Two 

Decades of Use. J. Clin. Hypertens. 2005; 7(9):531-537. 

250. Bigazzi, R., Bianchi, S., Batini, V., Guzzo, D. and Campese, V.M.: Metabolic Risk 

Factors and Markers of Cardiovascular and Renal Damage in Overweight Subjects. Am 

J Hypertens 2006; 19(4): 426-31. 

251. Ye, S-H., Zhong, H., Yanamadala, S., and Campese, V.M.: Oxidative Stress Mediates 

the Stimulation of Sympathetic Nerve Activity in the Phenol Renal Injury Model of 

Hypertension. Hypertension 2006; 48(15):309-315. 

252. Dua, R., Nadim, M.K., Soung, J. and Campese, V.M.: Renal Ischemia: How Commonly 

Does it Cause Renal Failure: Current Hypertension Reviews, 2006; 2:255-261. 

253. Bianchi, S., Bigazzi, R. and Campese, V.M.: Long-term effects of spironolactone on 

Proteinuria and kidney function in patients with chronic kidney disease. Kidney Int 2006. 

70(12):2116-23. 

254. Campese VM, Park J: The Kidney and Hypertension: 70 years of research. J 

Nephrology 19(6):691-8, 2006. 

255 Campese VM. Park J. Use of antagonists of aldosterone in patients with chronic kidney 

disease: Potential advantages and risks. J Hypertens 2006; 24(11):2157-9. 

256 Campese VM. Mitra N. Sandee D. Hypertension in renal parenchymal disease: why is it 

so resistant to treatment? Kidney Intl. 2006; 69(6):967-73. 

257. Campese, V.M., Sindhu, R.K., Ye, S-H, Bai, Y., Vaziri, N.D. and Jabbari, B.: Regional 

expression of NO synthase, NAD(P)H oxidase and superoxide dismutase in the rat 

brain. Brain Research. 2006; 1134 (1):27-32. 

258. Campese VM, Park J: HMG-Coa Reductase inhibitors and the kidney. Kindey Int 2007; 

71(12):1215-1222.


Page - 33 – 

259. Park, J. and Campese, V.M.: Clinical Characteristics of Resistant Hypertension: The 

Importance of Compliance and the Role of Diagnostic Evaluation in Delineating 

Pathogenesis. J. Clin. Hypertens. 2007; 9(1 suppl 1): 7-12. 

260. Bai, Y., Ye, S., Mortazavi, R., Campese, V.M., and Vaziri, N.D.: Effect of renal injuryinduced 

neurogenic hypertension on NO synthase, caveolin-1, Akt, calmodulin and 

soluble guanylate cyclase expressions in the kidney. Am J Physiol Renal Physiology 

292(3):F974-80, 2007. 

261. Campese, V.M., and Ye, S-H: A vitamin-E-fortified diet reduces oxidative stress, 

sympathetic nerve activity, and hypertension in the phenol-renal injury model in rats. J. 

Am. Soc. Hypertens.1(4), 2007, 242-250. 

262. Campese, V.M.: Diuretics are preferred over angiotensinn II-converting enzyme 

inhibitors for initial therapy of uncomplicated hypertension. Am. J. Kidney Dis. 2007; 

50(2): 197-202. 

263. Campese, V.M., Bedwani, D.N. and Park, J.: Hypertension, SNS overactivity, and the 

kidney: adverse consequences and therapeutic outlook. Cialogues Cardiovasc Med. 

2007; 12:199-205. 

264. Bigazzi, R., Bianchi, S., Buoncristiani, E., Campese, V.M.: Increased cardiovascular 

events in hypertensive patients with insulin resistance: A 13-year follow-up. Nutr Metab 

Cardiovasc Dis. Nutr. Metab. Cardiovasc. Dis. 2008, May; 18(4): 314-319. 

265 Campese, V.M. and Park, J.: Pathophysiology Of Renal Parenchymal. Hypertension 

Primer, Fourth Edition, AHA, Joseph L. Izzo, Jr., MD, Domenic A. Sica, MD, Henry R. 

Black, MD, Wolters Kluwer, Lippincott Williams & Wilkins, 2008, Chapter A50, Pg. 159- 

162. 

266 Campese VM, Vidhun J, Park J.: Hypertension in dialysis patients. In: The Principles 

and Practice of Dialysis, 4 th Edition(Henrich W [editor]). Lippincott Williams and Wilkins, 

Philadelphia, PA, Chapter 16, pp 289-322, 2009. 

267. Campese, V.M. and Park, J.: Pathophysiology Of Renal Parenchymal. Hypertension 

Primer, Fourth Edition, AHA, Joseph L. Izzo, Jr., MD, Domenic A. Sica, MD, Henry R. 

Black, MD, Wolters Kluwer, Lippincott Williams & Wilkins, 2008, Chapter A50, Pg. 159- 

162. 

268. Campese V, Park J. HMG Co-A Reductase Inhibitors and the Kidney. Kidney Int 71: 

1215-22, 2007. 

269. Campese V, Park J. HMG Co-A Reductase Inhibitors and Renal Function. Clin J Am 

Soc Nephrol. 2007. 2(6):1100-3. 

270. Campese VM, Bedwani DN, Park J. Hypertension, SNS overactivity, and the kidney: 

adverse consequences and therapeutic outlook. Dialogues in Cardiovascular Medicine. 

2007. 12(3): 19-25.


Page - 34– 

271. Park J, Campese VM, Middlekauff HR. Exercise pressor reflex in humans with endstage 

renal disease. Am J Physiol Regul Integr Comp Physiol. 2008, Oct; 295(4): 

R1188-R1194. 

272. Park J, Campese VM, Nobakht N, Middlekauff HR. Differential Distribution of Muscle 

and Skin Sympathetic Nerve Activity in Patients with End-Stage Renal Disease. J Appl 

Physiol. 2008 Dec;105(6):1873-6. 

273. Ku E, Park J, Vidhun J, Campese VM. The Hazards of Dual Renin-Angiotensin 

Blockade in Chronic Kidney Disease. Arch Intern Med. 2009;169(11):1015-1018. 

274. Bai, Y., Jabbari, B., Ye, S-H, Campese, V.M. and Vaziri, N.D.: Regional Expression of 

NAD(P)H Oxidase and superoxide Dismutase in the Brain of Rats with Neurogenic 

Hypertension. Am. J. Nephrol. 2009; 29:483-492. 

275. Ku, E., and Campese, V.M.: Role of aldosterone in the progression of chronic kidney 

disease and potential use of aldosterone blockage in children. Pediatr Nephrol. 

24:2301-2307, 2009 April. 

276. Ku, E., Nobakht, N. and Campese, V.M.: Lixivaptan: a novel vasopressin receptor 

antagonist. Expert Opin Investig Drugs 2009, 18:657-562. 

277. Ku, E. and Campese V.M.: Aldosterone and Hypertenson in African American. 

American Journal of Hypertension. 2009, 22(12):1234. 

278. Campese, V.M.: Oxidative Stress and Sympathetic Activity in Hypertension. AJH: 2010; 

23(5):456, 2010. 

279. Schneider, E.L. and Campese, V.M.: Adverse drug responses: An increasing threat to 

the well-being of older patients: Comment on "Development and validation of a score to 

assess risk of adverse drug reactions among in-hospital patients 65 years or older". 

Arch Intern Med. 2010 Jul 12;170(13):1148-9. 

280. Lu, Y., Ku, E. and Campese, V.M.: Aldosterone in the Pathogenesis of Chronic Kidney 

Disease and Proteinuria. Curr Hypertens. 2010; 12(4):303-306. 

281. Ku, E, Park J, Nasreen, T, and Campese VM: Metabolic and Dietary Influences on 

Sympathetic Nervous System Activity. Chapter 38:298. July 9, 2010. 

282. Bianchi S, Bigazzi R and Campese VM: Intensive versus conventional therapy to slow 

the progression of idiopathic glomerular diseases. AJKD 2010; 55(4): 671-681. 

283. A, Sordini C, Cavallini I, Bigazzi R and Campese VM: Angiotensin receptor blocker 

telmisartan improves insulin sensitivity in peritoneal dialysis patients. Perit Dial Int 2010; 

30(1): 66-71. 

284. Gill, I.S., Eisenber, M.S., Aron, M., Berger, A., Ukimura, O., Patil, M.B., Campese, V.M., 

Thangathurai, D. and Desai, M.M.: “Zero Ischemia Partial” Nephrectomy: Novel 

Laparo-scopic and Robotic Tehnique. Eur Urol. 2011 Jan;59(1):128-34. Epub 2010 Oct.


Page - 35– 

285. Cioni A, Sordini C, Cavallini I, Bigazzi R, and Campese V.M: Angiotensin receptor 

blocker telmisartan improves insulin sensitivity in peritoneal dialysis patients. Perit Dial 

Int 2010, Jan-Feb; 30(1)66-71. 

286. Bianchi S, Bigazzi R and Campese VM: Intensive versus conventional therapy to slow 

the progression of idiopathic glomerular diseases. Am J Kidney Dis 2010 Apri; 55(4): 

671-81. 

287. Campese, VM: Oxidative stress and sympathetic activity in hypertension. Am J 

Hypertens 2010 May; 23(5):456. 

288. Qazi YA, Qazi S, Maqbool I, Smogorzewski M, Sher L, Campese V: Outcomes of 

kidney transplant recipients with ESRD secondary to C1q nephropathy. Am J 

Transplant Vol 10(s4):pg 524. 2010. 

289. Ku, E., Park, Jeanie, Nasreen, T. and Campese, V.M.: Metabolic and Dietary 

influences on Sympathetic Nervous System Activity. Nutritional and Metabolic Bases of 

Cardiovascular Disease, 1 st Edition: Mario Mancini, Jose M. Ordovas, Gabriele Riccardi, 

Paolo Rubba and Pasquale Strazzullo, Wiley-Blackwell, 2011; Chapter 38: 298-302. 

290. Campese VM, Ku E and Park J: Sympathetic renal innervations and resistant 

hypertension. Int J Hypertens 2011. (In Process). 

291. Campese VM, Ku E, Bigazzi R and Bianchi S: Do HMG-CoA reductase inhibitors 

improve kidney function? The saga continues. J Nephrol. 2011; 24(5):550-553.


Page - 36– 

Abstracts 

1. AMERIO, A., V.M. Campese, P. Coratelli, et al: Glomerulonephritis in typhoid fever. Vth 

Internat Congress Nephrol 316, 1972. 

2. CAMPESE, V.M., V. DeQuattro: Decreased responsiveness of serum 

dopamine-hydroxylase (DBH) activity in primary hypertension. Fed Proc 34: 777, 1975. 

3. AMERIO, A, P Coratelli, VM Campese, et al: Acute renal failure and jaundice: Physiopathologic 

and prognostic remarks. VIth internat Cong nephrol, Florence, June 8-12, 

1975. 

4. CAMPESE, VM, M. DeQuattro, Y. Miura, D. Meijer: Biochemical markers of sympathetic 

nerve activity and renin in primary hypertension. Pharmacologist 17: 227, 1975. 

5. DeQuattro, V., V.M. Campese, Y, Miura, M. Esler: Sympathotonia. 4th Meeting of the 

Internat Soc of Hypertension, Sydney, Australia, 24th-26th February, 1976. 

6. CAMPESE, V.M., M. Myers, V. DeQuattro: Raised plasma catecholamines in "high" 

renin primary hypertension. Clin Res 24: 121A, 1976. 

7. CAMPESE, V.M., M. Myers, V. DeQuattro: Sympathetic nerve hyperactivity in "high" 

renin primary hypertension: Effects of Propranolol. Clin Res 25: 88A, 1977. 

8. DeQUATTRO, V., B. Barbour, V. Campese, E. Finck, L. Miano, M. Esler: Raised 

plasma norepinephrine in high renin hypertension: Effects of angiotensin II blockade. 

Fed Proc 36: 407, 1977. 

9. CAMPESE, V.M., M. Myers, L. Miano, V. DeQuattro: Sympathetic nerve hyperactivity in 

"high" renin primary hypertension: Effects of propranolol and saralasin. Clin Res 25: 

211-A, 1977. 

10. EIDE, I., V.M. Campese, D. Meijer, V. DeQuattro: Basal sympathetic tone judged by 

orthostatic blood pressure responses in patients with primary hypertension. Clin Res 

25: 219-A, 1977. 

11. CAMPESE, V.M., M.R. Myers, V. DeQuattro: Sympathetic nervous system and renin in 

the regulation of blood pressure in normal volunteers. Clin Res 26: 119-A, 1978. 

12. CAMPESE, V.M., M.R. Myers, V. DeQuattro: Sympathetic nerve function in low renin 

primary hypertension. Clin Res 26: 361-A, 1978. 

13. CAMPESE, V.M., V. DeQuattro: Role of sympathetic nervous system and 

renin-angiotensin-aldosterone system in cardiovascular homeostasis in normal man. 

VII th Internat Congress of Nephrol, Montreal, June 18-23, 1978. 

14. CAMPESE, V.M., M.R. Myers, V. DeQuattro: Neurogenic factors in low renin primary 

hypertension. Vth Scientific Meeting of the Intern Soc of Hyperten., Paris, France, June 

12-14, 1978.


Page - 37 - 

15. KEUSCH, G., P. Weidmann, V. Campese, D.B.N. Lee, S.G. Massry: Efficacy and limitations 

of minoxidil therapy in refractory hypertension. Kidney Internat 13: 538, 1978. 

16. ROMOFF, M.S., V.M. Campese, K. Lane, S.G. Massry: Mechanism of autonomic 

dysfunction in uremia: Evidence for reduced end organ response to norepinephrine. 

11th Annual Meeting, Am Soc Nephrology, November 20-21, 1978. 

17. CAMPESE, V.M., M.S. Romoff, N. Telfer, P. Weidmann, S.G. Massry: Clonidine in the 

evaluation of neurogenic factors in essential hypertension. 11th Annual Meeting of the 

Am Soc of Nephrology, New Orleans, November 20-21, 1978. 

18. CAMPESE, V.M., M.S. Romoff, N. Telfer, P. Weidmann, S.G. Massry: Clonidine in the 

evaluation of neurogenic factors in essential hypertension. Clin Res 27: 65a, 1979. 

19. CAMPESE, V.M., M.S. Romoff, D. Levitan, K. Lane, S.G. Massry: Reduced end-organ 

response to norepinephrine in uremia: A mechanism of autonomic dysfunction. Am 

Soc Nephr, Boston, Mass: 181A, November 18-20, 1979. 

20. CAMPESE, V.M., D. Stein, V. DeQuattro: Treatment of severe hypertension with 

minoxidil: Advantages and limitations. Toxicology, 1979. 

21. CAMPESE, V.M., M.S. Romoff, K. Lane, D. Levitan and S.G. Massry: Sympathy nerve 

activity (SNA) and hypertension in patients with end-stage renal failure (ESRF). Clin. 

Res. 28:36A, 1980. 

22. CAMPESE, V.M., M.S. Romoff, D. Levitan, Y. Saglikes, R. Friedler, S.G. Massry: 

Abnormal relationship between sodium intake and plasma norepinephrine (NE) in 

patients with essential hypertension. Secondary Forms of Hypertension: Current 

Diagnosis and Management. Montecatini-Terme, Italy May 6-8, 1980. 

23. CAMPESE, V.M., M. Romoff, P. Weidmann, S.G. Massry: Role of sympathetic nerve 

inhibition and body sodium-volume state in the antihypertensive action of clonidine in 

essential hypertension: Secondary Forms of Hypertension: Diagnosis and Management. 

Montecatini-Terme, Italy, May 6-8, 1980. 

24. CAMPESE, V.M., M.S. Romoff, D. Levitan, K. Lane, S.G. Massry: Autonomic nerve 

(ANS) dysfunction in uremia. 7th Scientific Meeting, Intern Soc Hypertension. New 

Orleans, May 11-14, 1980 (p.17). 

25. CAMPESE, V.M., M.S. Romoff, D. Levitan, Y. Saglikes, R.M. Friedler, S.G. Massry: 

Abnormal relationship between sodium (Na) intake and plasma norepinephrine (NE) in 

salt-sensitive patients with essential hypertension (EH). 13th Annual Meet Am Soc 

Nephrol, Washington, D.C., 57A, Nov. 23-25, 1980. 


Role of autonomic nerve (ANS) dysfunction in the genesis of impotence in uremia. 

VIIIth Internat Congress of Nephrol, Athens, 1981.


Page - 38- 

27. LEVITAN, D, VM Campese, MS Romoff, SG Massry: Autonomic neuropathy in patients 

with acute renal failure (ARF). VIIIth Internal Congress of Nephrol, Athen, 1981. 

28. LEVITAN, D., V.M. Campese, M,S. Romoff, S.G. Massry: Mechanisms of 

antihypertensive activity of clonidine in patients with mild to moderate renal failure. VIIIth 

internat Congress of Nephrol, Athen, 1981. 

29. CAMPESE, V.M.: Evidence for autonomic nervous system dysfunction in patients with 

acute renal failure (ARF). The Tel Aviv Symposium on Acute Renal Failure, 1981. 

30. CAMPESE, V.M.: Abnormal relationship between sodium intake and sympathetic 

nervous system in salt-sensitive patients with essential hypertension. Lewis K. Dahl 

Symposium on the Interrelation of Salt and Hypertension. Brookhaven, Long Island, 

May 7-8, 1981. 

31. SAGLIKES, Y., V.M. Campese, N. Brautbar, R. Barndt, S.G. Massry: Hemodynamic 

effects of phosphate depletion in rats. 5th Internat Workshop on Phosphate and Other 

Minerals, New York, N.Y. Sept. 24-27, 1981, 88A. 


Autonomic nervous system dysfunction and impotence in uremia. 14th Meet Am Soc 

Nephrology, Washington, D.C., Nov. 22-24, 1981. 

33. SAGLIKES, Y., V.M. Campese, S.G. Massry: Effect of parathyroid hormone (PTH) and 

its interaction with norepinephrine and angiotensin II on mean blood pressure. 14th 

Meet Am Soc Nephrol, Washington, D.C. Nov. 22-24, 1981. 

34. CAMPESE, V.M., D. Levitan, M.S. Romoff, Y. Saglikes, S.G. Massry: Effect of 

sympathetic nerve (SNS) inhibition on renal handling of sodium in hypertensives with 

normal (NRF) or impaired renal function (CRF). Clinical Res 30:48A, 1982. 

35. SAGLIKES, Y., V.M. Campese, N. Brautbar, R. Barndt, S.G. Massry: Effect of 

phosphate depletion (PD) on mean blood pressure (MBP) and vascular reactivity to 

norepinephrine and angiotensin II in rat. Clin Res 30: 339A, 1982. 

36. CAMPESE, V.M., D.Levitan, M.S. Romoff, Y. Saglikes, I. Sajo, S.G. Massry: Effect of 

sympathetic nerve inhibition on renal handling of sodium in hypertensives with normal 

(NRF) or impaired renal function (CRF). 9th scientific Meeting of the International 

Society of Hypertension, Mexico City, Feb. 1982. 

37. CAMPESE, V.M., Y. Saglikes, S.G. Massry: Effect of parathyroid hormone (PTH) and 

its interaction with norepinephrine and angiotensin II on mean blood pressure. 9th Sci 

Mth of the Internat Soc of Hypertension. Mexico City, Feb. 1982. 

38. CAMPESE, V.M., Y. Saglikes, N. Brautbar, R. Barndt, S.G. Massry: Effect of hosphate 

depletion on blood pressure. 15th Meeting of the Am. Soc. of Nephrology, Dec. 1982.


Page – 39 - 

39. SAGLIKES, Y., V.M. Campese, S.G. Massry: Mechanism of the hypotensive action of 

the intact and amino terminal fragment of parathyroid hormone. 15th Meeting of the 

American Society of Nephrology, Dec. 1982. 

40. CHANDRARATNA, P.A., M. Nanna, A. Nimalasuriya, V. Campese, E. Feinstein, J. 

Collins, S. Massry, S. Rahimtoola: Determination of contribution of arteriovenous 

fistulae to total cardiac output by Doppler computer. 32nd Annual Scientific Session, 

American College of Cardiology, March 20-24, 1983, New Orleans, Louisiana. 

41. CAMPESE, V.M., Y. Saglikes, N. Brautbar, R. Barndt, S.G. Massry: Hemodynamic 

consequences of phosphate depletion in rats. Clin Res 31: 381A, 1983. 

42. CAMPESE, V.M., R. Bream, P.A.N. Chandraratna, S.G. Massry, S.H. Rahimtoola: 

Subdiaphragmatic fluid mimicking loculated pericardial effusion (PE) on the 

echocardiogram. 16th Annual Meeting, The American Society of Nephrology, 

Washington, D.C., December 4-7, 1983. 

43. COLLINS, J., S.G. Massry, V.M. Campese: Indomethacin improves the altered vascular 

response to norepinephrine (NE) in uremic patients. 16th Annual Meeting, The 

American Society of Nephrology, Washington, D.C., Dec. 4-7. 1983. 

44. ISEKI, K., S.G. Massry, V.M. Campese: Interaction between parathyroid hormone 

(PTH) and hypercalcemia (Ca) in the genesis of hypertension in primary 

hyperparathyroidism. 16th Annual Meeting. The Am Soc of Nephr, Washington, D.C., 

Dec. 4-7, 1983. 

45. BREAM, R., V.M. Campese, S.G. Massry, S.H. Rahimtoola and P.A.N. Chandraratna: 

Subdiaphragmatic fluid loculated pericardial effusion on the echocardiogram. Clin. Res. 

32:70A, 1984. 

46. NADLER, J.L., M. McKay, V.M. Campese, R. Horton: Prostacyclin modulates the 

vascular action of calcium. Clin Res 1984. 

47. CHANDRARATNA, P.A.N., M. Nanna, A. Nimalasuriya, V. Campese, E. Feinstein, J. 

Collins, S.G. Massry, S. Rahimtoola: Determination of contribution of arteriovenous 

fistulae to total cardial output by Doppler computer. 32nd Ann Science Session Am 

College of Cardiol, March 20-24, 1984, New Orleans. 

48. ELKAYAM, U., L. Weber, V.M. Campese, S.G. Massry, S.H. Rahimtoola: Acute effect of 

arterial vasodilation with nifedipine on renal hemodynamics in patients with severe 

chronic heart failure. Proc 33rd Meeting, College of Cardiol, Dallas, Texas, March 

25-29, 1984. 

49. ISEKI, K., S.G. Massry, V.M. Campese: Role of parathyroid hormone in the genesis of 

reduced pressor response to agonists in uremia. IXth Int Congress Nephrol, Los 

Angeles, California, June 11-16, 1984, 348A. 

50. NADLER, J.L., M. McKay, V.M. Campese, R. Horton: Prostacyclin - a specific modulator 

of the vascular effect of calcium in man. Clin Res 32: 534, 1984.


Page - 40 – 

51. NADLER, J.L., M. McKay, V.M. Campese, R. Horton: Evidence for a 

calcium-prostacyclin modulating system in man. Int Prostagl Meeting, Kyoto, Japan, 

November 1984. 

52. CAMPESE, V.M., K. Iseki, J. Collins, S.G. Massry: Role of parathyroid hormone (PTH) 

and prostaglandin in the reduced vascular response to norepinephrine in chronic renal 

failure. 17th Ann Meeting of the American Soc of Nephrol, December 9-12, 1984. 

53. ISEKI, K., Massry, S.G., Campese, V.M.: Hypercalcemia and Hypertension: Role of 

Parathyroid Hormone. 18th Ann Meeting of the American Soc. of Nephrol, Dec. 15-18, 

1985 (99A). 

54. EL BELBESSI, S., Brautbar, N., Anderson, K., Campese, V.M., and Massry, S.G.: 

Effect of Chronic Renal Failure on Heart: Role of Secondary Hyperparathyroidism 18th. 

Ann Meeting Am Soc Nephrol, December 15-18, 1985 (168A). 

55. CAMPESE, V.M., Iseki, K., Massry, S.G.: The Effect of Na+-K+ATPase Inhibition on the 

Vascular Smoot Muscle Response to Calcium 19th. Ann Meeting Amer Soc Nephrol, 

Dec 7-10, 1986. 

56. BHASKARAN, D., Massry, S.G., Campese, V.M.: Effect of Phosphate Depletion on 

Brain Catecholamines Content In The Rat 19th. Ann Meeting Amer Soc Nephrol, 

December 7-10, 1986, (185A). 

57. KULICK, D., McIntosh, N. Hsueh, W., Campese, V.M., Rahimtoola, S.H., Elkayam, U.: 

Diltiazem in patients with severe left ventricular systolic dysfunction: Evaluation of 

central and renal hemodynamic response. Clin Res 35:108A, 1987. 

58. ROTH, A., Campese, V.M., Hsueh, W., McIntosh, N., Rahimtoola, S.H., Elkayam, U.: 

Effects of Intravenous Amrinone On Renal Hemodynamics and Neurohumonal Status In 

Patients with Severe Chronic Heart Failure. Clin Res 35: 113A, 1987. 

59. ROTH, A., Campese, V.M., Hsueh, W., McIntosh, N., Rahimtoola, S.H., Elkayam, U.: 

Failure of Intravenous Amrinone To Improve Renal Hemodynamics and neurohumonal 

status in patients with severe Heart Failure. JACC 9: 103A, 1987. 

60. FADDA, G., Massry, S.G., El-Rafai, M., Campese, V.M.: Adrenergic Receptors and 

Vascular Responsiveness In Chronic Renal Failure. 20th Ann Meeting Amer Soc 

Nephrol, December 13-16, 1987 (148A). 

61. SMOGORZEWSKI, M., Campese, V.M., Massry, S.G.: Abnormal norepinephrine (NE) 

Metabolism In Brain Synaptosomes (SY) of Rats with Chronic Renal Failure (CRF). 

Role of Parathyroid Hormone (PTH). 20th Ann Meeting Amer Soc Nephrol. December 

13-16, 1987 (238A). 

62. JAMISON, M., Widerhorn, J., Weber, L., Campese, V.M., Elkayam, U.: Central and 

Renal hemodynamic effects of new agonist at peripheral dopamine and Beth 

2-receptors (dopexamine) in heart failure, 61st Sci. Sessions Am Heart Assoc., 

Washington, D.C., 1988.


Page - 41 – 

63. CAMPESE, V.M., Liu, C., Ballard, J.: Catecholamines content in brain cardiovascular 

control centers in uremic rats. 22nd Annual Meeting Am. Soc. Nephrol., Washington, 

D.C., December 3-6, 1989. (195A). 

64. GADALLAH, M., Massry, S.G., Campese, V.M.: Intestinal absorption of calcium in 

patients with essential hypertension. 22nd Annual Meeting Am. Soc. Nephrol., 

Washington, D.C., December 3-6, 1989, (211A). 

65. LIU, C., Ballard, J., Campese, V.M.: Calcium inhibits renal sympathetic nerve activity 

(RSNA) in rats. 22nd Ann. Meet. Am Soc Nephrol, Washington, D.C. December 3-6, 

1989, (365A). 

66. BUCHANAN, T., Sipos, G., Liu, C., Campese, V.M.: Hypertension in spontaneously 

hypertensive rats. Clin. Res. 1990. 

67. PARISE, M., Bigazzi, R., Liu, C., Campese, V.M.: Calcium channel antagonists correct 

the abnormality in renal sodium handling in salt-sensitive patients with essential 

hypertension. 5th Sci Meet Am Soc Hypertension, New York, N.Y., May 17-21, 1990. 

68. LIU, C., Ballard, J., Campese, V.M.: Inhibitory effect of calcium on renal sympathetic 

nerve activity. 13th Meet Int Soc Hypertension, Montreal, Canada, June 24-29, 1990. 

69. BUCHANAN, T., Sipos, G., Liu, C., Campese, V.M.: Hyperinsulinemia in spontaneously 

hypertensive rats (SHR). 13th Meet Int Soc Hypertension, Montreal, Canada, June 

24-29, 1990. 

70. GADALLAH, M., Massry, S.G., Horst, A.L., Campese, V.M.: Intestinal absorption of 

calcium and calcium metabolism in essential hypertension. 13th Meet Int Soc 

Hypertension, Montreal, Canada, June 24-29, 1990. 

71. SIPO, G., Buchanan, T., Campese, V.M., Liu, C.: Insulin resistance and paradoxically 

enhanced glucose tolerance in spontaneously hypertensive rats. 50th Sci Meet Am 

Diabetes Eds, Atlanta, Georgia, June 16-19, 1990. 

72. PARISE, M., Bigazzi, R., Liu, C., Campese, V.M.: Effect of nifedipine on the renal 

function curve in salt-sensitive patients with essential hypertension. 13th Meet Int Soc 

Hypertension, Montreal, Canada, June 24-29, 1990. 

73. GACIONG, Z., Alexiewicz, J.M., Parise, M., Karubian, F., Massry, S.G., Campese, 

V.M.: Effect of dietary sodium intake on intracellular calcium in lymphocytes of 

salt-sensitive hypertensive patients. JASN 1990; 1: 489A. 

74. BIGAZZI, R., Bianchi, J., Baldari, G., Campese, V.M.: Microalbuminuria in patients with 

essential hypertension: Effect of enalapril and nitrendipine. JASN 1990; 1: 505A. 

75. CAMPESE, V.M., Parise, M., Karubian, F., Bigazzi, R.: Renal hemodynamic adaptation 

to high sodium intake in black patient with essential hypertension: Effect of Nifedipine. 

Am. J. Hypertension 1991; 4: 17A.


Page – 42 - 

76. BIGAZZI, R., Bianchi, J., Baldari, G. and Campese, V.M.: Effects of enalapril and 

nicardipine on urinary albumin excretion in patients with chronic renal insufficiency: a 

one year follow-up. Am. J. Hypertension 1991; 4: 87A. 

77. BIGAZZI, R., Kogosov, E., Campese, V.M.: Derangement of the hypothalamic-pontine 

regulation of blood pressure in uremic rats. JASN 1991; 2:472A. 

78. BIANCHI, S., Bigazzi, R., Baldari, G., and Campese, V.M.: Microalbuminuria in patients 

with essential hypertension: Effect of four different antihypertensive agents. JASN 1991; 

2:486A. 

79. KARUBIAN, F., Bigazzi, R., Parise, M., Campese, V.M.: Increased vascular response to 

agonists in salt-sensitive patients with essential hypertension. JASN 1991; 2:492A. 

80. CAMPESE, V.M.: Norepinephrine turnover in the brain of uremic rats. Blood Purification 

1991, 9:212. 

81. BIANCHI, S., Bigazzi, R., Sgherri, G.P., Baldari, G., Campese, V.M.: Long term effect 

of converting enzyme inhibitors on microalbuminuria in essential hypertension. Am. J. 

Hypertension 1992, 5. 

82. ALEXIEWICZ, J.M., Gaciong, Z., Parise, M., Karubian, F., Massry, S.G. and V.M. 

Campese: Intracellular calcium (Ca++) in lymphocytes of salt-sensitive (SS) patients 

with essential hypertension: effect of dietary sodium intake and nifedipine-5th Europ 

Meet on Hypertension, Milan, Italy June 7-10, 1991. 

83. CAMPESE, V.M., Parise, M., Karubian, F., Bigazzi, R.: Deranged renal hemodynamic 

adaptation to high sodium intake in salt-sensitive patients with essential hypertension: 

Effect of nifedipine GITS. 5th Europ Meet on Hypertension, Milan, Italy June 7-10, 

1991. 

84. BIANCHI, S., Mazzoni, A., Bigazzi, R., Baldari, G., Campese, V.M.: Effect of converting 

enzyme inhibitors (CEI) on renal function in hypertensive patients with chronic renal 

failure. JASN 1992; 3:280A. 

87. CAMPESE, V.M.: Sympathetic nerve activity and hypertension in rats with chronic renal 

failure. Blood purification 1993; 11:30A. 

88. BIANCHI, S., Bigazzi, R., Valtriani, C., Chiapponi, I., Sgherri, G., Baldari, G., Campese, 

V.M.: Elevated serum lipoprotein (a) in patients with essential hypertension and 

microalbuminuria. Am. J. Hypert. 1993; 6:46A. 

89. BIGAZZI, R., Bianchi, S., Sgherri, G., Baldari, G., Campese, V.M.: Elevated serum 

insulin in patients with essential hypertension and microalbuminuria. Am. J. Hyperten. 

1993; 6:52A. 

90. BIGAZZI, R., Kogosov, E., Campese, V.M.: Increased sympathetic nervous system 

activity and hypertension in rats with chronic renal failure. JASN 1993; 4:507A. 

91. KOGOSOV, E., Bigazzi, R., Campese, V.M.: Renal sensory denervation prevents 

hypertension in rats with chronic renal failure. JASN 1993; 4:515A.


Page – 43 - 

92. BIANCHI, S., Bigazzi, R., Valtriani, C., Chiapponi, I, Sgherri, G.P., Baldari, D., Baldari, 

G., Campese, V.M.: Increased serum levels of lipoprotein (a) in patients with essential 

hypertension and microalbuminuria. JASN 1993; 4:529. 

93. BIGAZZI, R., Bianchi, S., Baldari, G., Campese, V.M.: Diurnal variation of blood 

pressure and microalbuminuria in patients with essential hypertension. JASN 1993; 

4:529. 

94. CAMPESE, V.M., Tawadrous, M.N., Haidan, A.N., Chervu, I.: Cytosolic calcium in 

platelets: a marker of salt-sensitivity in essential hypertension. JASN 1993; 4:530. 

95. CAMPESE, V.M., Raij, L: Reduced secretion of atrial natriuretic factor in salt-sensitive 

patients with essential hypertension. JASN 1993; 4:530. 

96. BIGAZZI, R., Bianchi, S., Baldari, D., Sgherri, G.P., Baldari, G., Campese, V.M.: 

Microalbuminuria and abnormal renal hemodynamics in salt-sensitive patients with 

hypertension. JASN 1993; 4:575. 


brown fat of rats with chronic renal failure. JASN 1993; 4: 765. 

98. BIGAZZI, R., Bianchi, S., Baldari, G., Campese, V.M.: Microalbuminuria and renal 

hemodynamics in salt-sensitive hypertensive patients. 15th Scient Meet Int Soc 

Hypertension, Melbourn, Australia. March 20-24, 1994. 

99. CAMPESE, V.M., Tawadrous, M., Chervu, I.: Cytosolic calcium [Ca2+]i in platelets: a 

marker of salt-sensitivity in essential hypertension. 15th Scient Meet Int Soc 


100. CAMPESE, V.M., Raij, L.: Reduced secretion of atrial natriuretic factor in salt-sensitive 

patients with essential hypertension. 15th Scient Meet Int Soc Hypertension, Melbourn, 

Australia. March 20-24, 1994. 

101. BIANCHI, S., Bigazzi, R., Baldari, G., Campese, V.M.: Microalbuminuria and diurnal 

variations of blood pressure in essential hypertension. 15th Scient Meet Int Soc 


102. BIGAZZI, R., Kogosov, E., Campese, V.M.: Increased sympathetic nervous system 

activity in rats with CRF. 15th Scient Meet Int Soc Hyper, Melbourn, Australia. Mar 

20-24, 1994. 

103. BIANCHI, S., Bigazzi, R., Vartriani, C., Chiapponi, I., Sgherri, G.P., Baldari, G., 

Campese, V.M.: Elevated serum insulin in patients with essential hypertension and 

micro-albuminuria. 15th Scient Meet Int Soc Hypertension, Melbourn, Australia. March 

20-24, 1994. 

104. BIGAZZI, R., Bianchi S., Baldari, G., Campese, V.M.: Microalbuminuria and renal 

hemodynamics in salt-sensitive hypertensive patients. XXXI st Congress of the 

E.D.T.A., Vienna, Austria, 1994.


Page - 44 - 

105. CAMPESE, V.M., Bigazzi, R., Kogosov, E.: Is hypertension in rats with chronic renal 

failure due to neurogenic factors? 48th Ann Conf Council for High Blood Pressure, 

Chicago, September 27-30, 1994. 

106. CAMPESE, V.M., Oparil, S., Raij, L.: Atrial natriuretic factor in black salt-sensitive 

hypertensive patients. 48th Ann Conf Council for High Blood Pressure, Chicago, 

September 27-30, 1994. 

107. CAMPESE, V.M., Tawadrous, M., Chervu, I., Goldstein, D.: Urinary catecholamines in 

black salt-sensitive patients with essential hypertension. 27th Annual Meeting, 

American Society of Nephrology, Orlando, Florida, October 26-29, 1994. JASN 1994; 

5:558. 

108. CAMPESE, V.M., Kogosov, E.: Renal afferent impulses to the brain cause neurogenic 

Hypertension in rats with CRF. 27th Annual Meeting, American Society of Nephrology, 

rlando, Florida, October 26-29, 1994. JASN 1994; 5:536. 

109. KOGOSOV, E., Campese, V.M.: Role of nitric oxide synthesis in hypertension in rats 

with chronic renal failure. 27th Annual Meeting, American Society of Nephrology, 

Orlando, Florida, October 26-29, 1994. JASN 1994; 5:543. 

110. BIANCHI, S., Bigazzi, R., Baldari, G., Campese, V.M.: Insulin sensitivity in 

salt-sensitive patients with essential hypertension. 27th Annual Meeting, American 

Society of Nephrology, Orlando, Florida, October 26-29, 1994. JASN 1994; 5:557. 

111. CAMPESE, V.M., Raij, L.: Effect of varied salt intakes on serum levels of nitric oxide in 

human essential hypertension. 27Ht Annual Meeting, American Society of Nephrology, 

Orlando, Florida, October 26-29, 1994. JASN 1994; 5:558. 

112. BIANCHI, S., Bigazzi, R., Baldari, G., Campese, V.M.: Elevated serum insulin in 

hypertensive patients with microalbuminuria. 27th Annual Meeting, American Society 

of Nephrology, Orlando, Florida, October 26-29, 1994. JASN 1994; 5:556. 

113. BIGAZZI, R., Bianchi, S., Baldari, D., Baldari, G., Campese, V.M.: Microalbuminuria is 

a marker for atherosclerosis in patients with essential hypertension. 27th Annual 

Meeting, ASN, Orlando, Florida, October 26-29, 1994. JASN 1994; 5:557. 

114. CHANG, H-Y, McDonough, A.A., Campese, V.M.: Identification of the Na+Ca2+ exchanger 

in human platelets. Effect of high NaCl diet. 27th Annual Meeting, American 


115. CAMPESE, V.M., Kogosov, E., Koss, M.: Renal denervation prevents the progression of 

renal disease in the renal ablation model in rats. 27th Annual Meeting, American 


116. TUMMALA, P.P., Saad, M., Kumar, V., Campese, V.M.: Microalbuminuria among 

hispanics with type II diabetes (NIDDM): Prevalence and relationship to other risk 

factors. 27th Annual Meeting, American Society of Nephrology, Orlando, Florida, 

October 26-29, 1994. JASN 1994; 5:385.


Page - 45 - 

117. CAMPESE, V.M.: Increased insulin response to an oral glucose load in salt-sensitive 

patients with hypertension. Am. J. Hypertension (In Press). 

118. CAMPESE, V.M., KOGOSOV, E.: Renal afferent impulses to the brain cause 

neurogenic hypertension in rats with chronic renal failure. Baxter Extramural Grant, 

Ann. Meet. June 14-16, 1994. 

119. CAMPESE, V.M., TAWADROUS, M., BIANCHI, S.: Effect of Varied Salt Intakes and 

Nifedipine on Renal Hemodynamics in Diabetics With Hypertension (Htn). 28th Annual 

Meeting, American Society of Nephrology, San Diego, California. JASN 1995; 6:447. 

120. GADALLAH, M.F., EL-SHAHAWY, M., CAMPESE, V.M., TODD, J., KING, J.: Disparate 

Prognosis of Thrombotic Thrombocytopenic Purpura in HIV Infection with and without 

AIDS. 28th Annual Meeting, American Society of Nephrology, San Diego, California. 

JASN 1995; 6:464. 

123. CAMPESE, V.M., KOGOSOV, E.: Increased Norepinephrine Secretion From the 

Posterior Hypothalamus (PH) of 5/6 Nephrectomized (CRF) Rats. 28th Annual Meeting, 

American Society of Nephrology, San Diego, California. JASN 1995; 6:619. 

122. CHANG, H-Y., McDONOUGH, A.A., CAMPESE, V.M.: High Salt Intake Increases the 

Expression of the Alpha-1 Subunit of Na + , K + -ATPase (NKA) in Platelets of Salt- 

Sensitive Hypertensive Patients. 28th Annual Meeting, American Society of 

Nephrology, San Diego, California. JASN 1995; 6:619. 

123. BIGAZZI, R., BIANCHI, S., NENCI, R., CAMPESE, V.M.: Increased Carotid Artery 

Thickness in Salt-Sensitive Hypertensives. 28th Annual Meeting, American Society of 

Nephrology, San Diego, California. JASN 1995; 6:637. 

124. BIANCHI, S., BIGAZZI, R., BALDARI, G., CAMPESE, V.M.: Hyperinsulinemia and 

Circadian Variation of Blood Pressure (BP) in Essential Hypertension (EH). 28th 

Annual Meeting, American Society of Nephrology, San Diego, CA. JASN 1995; 6:637. 

125. CHANG, H-Y, BIANCHI, S, TAWADROUS, M, CAMPESE, VM: Effect of an acute saline 

load on cytosolic [Ca 2+ ]i in Platelets of Salt-Sensitive Patients with Hypertension. 28th 

Annual Meeting, American Society of Nephrology, San Diego, CA. JASN 1995; 6:638. 


brown fat of rats with chronic renal failure. JASN 1993; 4: 765. 

127. BIGAZZI, R., Bianchi, S., Baldari, G., Campese, V.M.: Microalbuminuria and renal 

hemodynamics in salt-sensitive hypertensive patients. 15th Scient Meet Int Soc 


128. CAMPESE, V.M., BIANCHI, S., BIGAZZI, R., RAIJ, L.: Atrial Natriuretic Peptide (ANP) 

is Reduced Both in White and Black Salt-Sensitive (SS) Hypertensives. 28th Annual 

Meeting, American Society of Nephrology, San Diego, California. JASN 1995; 6:638.


Page - 46 - 

129. CAMPESE, V.M., TAWADROUS, M., BIANCHI, S.: Reduced Renal PGE-2 Excretion in 

Salt-Sensitive (SS) Patients with Essential Hypertension (EH). 28th Annual Meeting, 

American Society of Nephrology, San Diego, California. JASN 1995; 6:753. 

130. YE, S., CAMPESE, V.M.: The Renal Nerves and Hypertension in Rats with Chronic 

Renal Failure (CRF). 29th Annual Meeting, American Society of Nephrology, New 

Orleans, Louisiana. JASN 1996; 7:1544. 

131. YE, S., CAMPESE, V.M.: The Rostral Ventral Medulla and Hypertension in Rats with 

Chronic Renal Failure. 29th Annual Meeting, American Society of Nephrology, New 

Orleans, Louisiana. JASN 1996; 7:1544. 

132. BIANCHI, S., BIGAZZI, R., CAMPESE, V.M.: Increased Cardiovascular Events in 

Patients with Hypertension (EH) and Microalbuminuria (FA). 29th Annual Meeting, 

American Society of Nephrology, New Orleans, Louisiana. JASN 1996; 7:1546. 

133. CAMPESE, V.M., MANN, A., WURGAFT, A.: Effect of L-Arginine on Systemic and 

Renal Hemodynamics in Salt-Sensitive Patients with Essential Hypertension. 29th 

Annual Meeting, American Society of Nephrology, New Orleans, LA. JASN 1996; 

7:1547. 

134. YE, S., NOSRATI, S., CAMPESE, V.M.: Nitric Oxide (NO) Modulates the Sympathetic 

Nerve (SNS) Control of Blood Pressure (BP) in Rats with Chronic Renal Failure (CRF). 

29th Annual Meeting, Am Soc of Nephr, New Orleans, Louisiana. JASN 1996; 7:1576. 

135. CAMPESE, V.M.: Nitric Oxide modulated the neurogenic control of blood pressure in 

rats with chronic renal failure. Blood Purificat. 1996; 15(Suppl I) I24. 

136. BIGAZZI, R., BIANCHI, S., AND V.M. CAMPESE: Increased urine albumin excretion 

(UAE) in salt-sensitive (SS) patients with hypertension (EH). Am. J. Hypertension 1996; 

9:13A. 

137. BIANCHI, S., TAWADROUS, M., AND V.M. CAMPESE: Renal hemodynamics in 

diabetics with hypertension: effects of high salt diet and nifedpine. Am. J. Hypertension 

1996; 9:128A. 

138. BIANCHI, S., BIGAZZI, R., BALDARI, D., V.M. CAMPESE: Hypertensive patients with 

reduced nocturnal dipping of blood pressure manifest increased carotid artery thickness 

and hyperinsulinemia. Am. J. Hypertension 1996; 9:131A. 

139. BIANCHI, S., BIGAZZI, R., BALDARI, G CAMPESE, V.M.: Microalbuminuria in patients 

with hypertension predicts cardiovascular and renal events. Am. J. Hypertension 1997; 

10:78A. 

140. CAMPESE, V.M., YE, S: Neurogeric factors in hypertension caused by renal injury. Am 

J Hypertens 1997; 10:8A.


Page - 47 - 

141. BIGAZZI, R., BIANCHI, S., BALDARI, D., CAMPESE, V.M.: Effect of various 

antihypertension drugs on microalbuminuria and progression of renal disease in 

essential hypertension (EH). 30th Annual ASN Meeting, San Antonio, Texas, JASN 

1997; 8:64A. 

142. YE, S., CAMPESE, V.M.: An acute renal injury may cause a permanent neurogenic 

elevation of blood pressure (BP) in the rat. 30th Annual ASN Meeting, San Antonio, 

Texas, JASN 1997; 8:312A. 

143. BIANCHI, S., BIGAZZI, R., BALDARI, G., CAMPESE, V.M.: Is Microalbuminuria (FA) a 

predictor of cardiovascular and renal events in essential hypertension (EH). 30th 

Annual ASN Meeting, San Antonio, Texas, JASN 1997; 8:316A. 

144. GACIONG, Z., BIGAZZI, R., PLACHA, G., RELIGA, P., PACZEK, L., CAMPESE, V.M.: 

Angiotensin I converting enzyme (ACE) gene polymorphism and salt-sensitivity in 

essential hypertension (EH). 30th Annual ASN Meeting, San Antonio, Texas, JASN 

1997; 8:316A. 

145. CAMPESE, V.M. AND YE, S.: Interleukin-1 (IL-1) gene expression in brain nuclei of rats 

with chronic renal failure (CRF). 30th Annual ASN Meeting, San Antonio, Texas, JASN 

1997; 8:316A. 

146. CAMPESE, V.M., YE, S-H, MOZAYENI, P., GAMBURD, M.: Interleukin-1 (IL-1$) and 

the central activation of sympathetic outflow in rats with chronic renal failure. Ann Conf 

Council on high blood pressure, 1998. 

147. MOZAYENI, P., CAMPESE, V.M., YE, S., GAMBURD, M.: In rats with chronic renal 

failure high salt intake aggravated hypertension by inhibition of nitric oxide expression. 

Ann. Conf. Council on high blood pressure, 1998. 

148. CAMPESE, V.M., YE, S-H., MOZAYENI, P., GAMBURD, M.: Interleukin-1 (IL-1$) 

modulation the central altivation of sympathetic outflow. Ann. Conf. Council on high 

blood pressure, 1998. 

149. CAMPESE, VM, YE, S-H, MOZAYENI, P, GAMBURD, M: Nephrectomy normalizes 

blood pressure in the phenol renal injury model of hypertension. American Society of 

Nephrology 31st Annual Meeting, Philadelphia, PA, October 25-28, 1998. ASN 

9:A1548, 1998. 

150. CAMPESE, V.M., YE, S-H, MOZAYENI, P., GAMBURD, M.: Interleukin-1 (IL-1$) inhibits 

the central activation of sympathetic (SNS) outflow in rats with chronic renal failure 

(CRF). American Society of Nephrology 31st Annual Meeting, Philadelphia, PA, 

October 25-28, 1998. ASN 9:A1549, 1998. 

151. MOZAYENI, P., CAMPESE, V.M., YE, S-H, GAMBURD, M.: High salt intake inhibits 

nitric oxide (NO) and aggravates hypertension (HTN) in rats with chronic renal failure 

(CRF). American Society of Nephrology 31st Annual Meeting, Philadelphia, PA, 

October 25-28, 1998. ASN 9:A1593, 1998.


Page - 48 - 

152. BIANCHI, S., BIGAZZI, R., NENCI, R., BALDARI, G., AND V.M. CAMPESE: 

Microalbuminuria is associated with greater risk of myocardial ischemia in patients with 

essential hypertension (EH). American Society of Nephrology 31st Annual Meeting, 

Philadelphia, PA, October 25-28, 1998. ASN 9:A1630, 1998. 

153. CAMPESE, VM, YE, S-H, MOZAYENI, P, GAMBURD, M: The activation of central sympathetic 

(SNS) outflow is regulated by interleukin-1 (IL-1$). ASN 31st Annual Meeting, 

Philadelphia, PA, October 25-28, 1998. ASN 9:A2025, 1998. 

154. CAMPESE, VM, YE, S-H, MOZAYENI, P, GAMBURD, M: Interrelations of Interleukin- 

1$, Nitric Oxide, Prostaglandins and Sympathetic Activity in the Regulation of Blood 

Pressure. ASN 32 nd Annual Meeting, Miami Beach, FL, Nov.1-8, 1999. ASN 10: 

A1730, 1999. 

155. CAMPESE, V.M., FERRARIO, C.M., RUDDY, M.C., GRIM, C.E., SMITH, R.D., 

LASSETER, K.C., SMITH, W.B., VARGAS, R., HABASHY, M.F., DELANEY, C.L., GE, 

Z., LIAO, W.: Omapatrilat or Lisinopril in salt-sensitive hypertensives. The American 

Society of Hypertension, Fifteenth Scientific Meeting, New York, NY, May 16-20, 2000. 

AJN 13:15A, 2000. 

156. FERRARIO, C.M., V.M., SMITH, R.D., YUNIS, C., BRONIHAN, K.B., GRIM, C.E., V. 

CAMPESE, V.M., RUDDY, M., VESTERQUIST, O., LIAO, W. Angiotensin-(1-7) and 

vasopeptidase inhibition. The American Society of Hypertension, Fifteenth Scientific 

Meeting, New York, NY, May 16-20, 2000. AJN 13:23A, 2000. 

157. VESTERQUIST, O., CAMPESE, V.M., LIAO, W., MANNING, J.A., BRAGAT, N.J., 

DELANEY, C.L., FORD, N.F.: Omapatrilat increases plasma concentration of 

adrenomedullin in salt-sensitive hypertensives. The American Society of Hypertension, 

Fifteenth Scientific Meeting, New York, NY, May 16-20, 2000. AJN 13:125A, 2000. 

158. GRIM, C.E., CAMPESE, V.M., FERRARIO, C.M., LASSETER, K.C., RUDDY, M.C., 

VARGAS, R., SMITH, W.B., ABDURAHAMAN, A., VESTERQUIST, O., GE, Z., 

DELANEY, C.L., DITULLIO, L.J., LIAO, W.: Salt-sensitivity and ethnic variations: Reninangiotensin 

and natriuretic hormones. The American Society of Hypertension, Fifteenth 

Scientific Meeting, New York, NY, May 16-20, 2000. AJN 13:263A, 2000. 

159. CAMPESE, V.M. YE, S-H: Losartin Inhibits Sympathetic Nervous System (SNS) Activity 

in a Neurogenic Model of Hypertension in the Rat. American Society of Nephrology 33 rd 

Annual Meeting, Toronto, Ontario, Canada, October 11-16, 2000. JASN11:A1732, 

2000. 

160. CAMPESE, V.M., YE, S-H, GAMBURD, M., ZHONG, H.: Interleukin-1[$] (IL-1$) 

Mediates a Negative Feed-Back Loop on Sympathetic Activity (SNS) in Rats. American 

Society of Nephrology 33 rd Annual Meeting, Toronto, Ontario, Canada, October 11-16, 

2000. JASN 11:A1733, 2000.

Curriculum Vitae Vito M.Campese, MD 

Page - 49- 

161. YE, S-H, YOUN, JH, CHOI, CS, CAMPESE, VM: Increased Sympathetic Nervous 

System (SNS) Activity May Cause Insulin-Resistance in Hypertensive Rats. ASN 33 rd 

Annual Meeting, Toronto, Ontario, Canada, Oct. 11-16, 2000. JASN 11:A2262, 2000. 

162. BANCHI, S., BIGAZZI, R., CAIAZZA, A., CAMPESE, V.M.: Atorvastatin Slows the 

Progression of Renal Failure and Reduces Proteinuria in Patients with Renal 

Insufficiency and Hypercholesterolemia. The ASN ASN/ISN World Congress of 

Nephrology, San Francisco, CA, October 10-17, 2001. JASN 12: A0990. 

163. CAMPESE, V.M., YE, S-H, ZHONG, H.: Downregulation of nNOS and Interleukin 

1ßMediates Angiotensin II Dependent Central Stimulation of the Sympathetic Nervous 

System. The American Society of Nephrology, ASN/ISN World Congress of 

Nephrology, San Francisco, CA, October 10-17, 2001. JASN 12:A2387. 

164. YANG, L., LEONG, P.K.K., YE, S-H., CAMPESE, V.M., McDONOUGH.: Recruiting of 

NHE3 to Apical Brush Border during Phenol Injury Induced Hypertension. The 

American Society of Nephrology, ASN/ISN World Congress of Nephrology, San 

Francisco, CA, October 10-17, 2001. JASN 12:A2463. 

165. CAMPESE VM, YE S-H, ZHONG H.: Reactive Oxygen Species (ROS) Stimulate 

Central and Peripheral Sympathetic Nervous System (SNS) Activity. The American 

Society of Nephrology, ASN/ISN World Congress of Nephrology, Philadelphia, PA, 

October 30 – November 4, 2002. JASN 13:SU-P0215. 

166. CAMPESE VM, YE S-H, ZHONG H. Oxidative stress mediates Angiotensin IIdependent 

stimulation of sympathetic nerve activity. The Faseb J 2003;17:96/10. 

167. CAMPESE VM, YE S-H, ZHONG H. Angiotensin II stimulates sympathetic nerve activity 

through activation of oxidative stress. ASH May 16 th , 2003. 

168. CAMPESE, VM, Ye, S-H, Zhong, H: Renal Injury and Central Sympathetic Nervous 

System (SNS) Activation: Role of Angiotensin II AT-1 Receptors, The ASN Program and 

Abstracts, San Diego, CA, Nov 12-17, 2003. JASN 14:F-P0377. 

169. Ye, S-H, Zhong, H., and CAMPESE, V.M.: Angiotensin II (Ang II) Stimulation of the 

Sympathetic Nervous System (SNS) Is Mediated in Part by Increased Abundance of 

Alpha-1 Adrenergic Receptors (AR). The ASN Program and Abstracts, San Diego, CA, 

November 12-17, 2003. JASN 14:SA-PO099. 

170. Ye, S-H, Zhong, H., and CAMPESE, V.M.: Renal Injury and Central Sympathetic 

Nervous System (SNS) Activation: Role of Alpha-1a and Alpha-b Adrenergic Receptors 

(AR). The American Society of Nephrology, Program and Abstracts, San Diego, CA, 

November 12-17, 2003. JASN 14:SA-P0133. 

171. CAMPESE, VM, Ye, S-H, Zhong, H: Increased Oxidative Stress Mediates Angiotensin II 

(Ang II) Stimulation of the Sympathetic Nervous System (SNS) in the Brain. The 

American Society of Nephrology, Program and Abstracts, San Diego, CA, November 

12-17, 2003. JASN 14:SA-PO1018.

Curriculum Vitae Vito M.Campese, MD 

Page - 50- 

172. BIGAZZI, R., Bianchi, S., and Campese, V.M.: Optimizing The Treatment Of Patients 

With Chronic Kidney Disease. The American Society of Nephrology of Hypertension, 

22 nd Annual Scientific Meeting Exposition, May 19-22, 2007, Hyatt Regency Chicago, 

IL. The Journal of Clinical Hypertension Suppl. A Vol. 9:5, 2007. 

173. Campese VM, Ku E and Park J: Sympathetic renal innervations and resistant 

hypertension. Int J Hypertens 2011. (Jan 20, 2011:814354). 

MSWord/CAMPESE-CV/Revised/mla: 1/9/2012

Curriculum Vitae - Oxford Journals

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?